FGL (FGLHF) 10-Q 7 May 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Apr. 30, 2019
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Trading Symbol	FG
Entity Registrant Name	FGL Holdings
Entity Central Index Key	0001668428
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		221,660,974

Investments - Proceeds From The

Investments - Proceeds From The Sale of Fixed-maturity available for-sale-securities - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Available-for-sale Securities [Line Items]
Document Period End Date	Mar. 31, 2019
Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:	$ 962	$ 3,286
Available-for-sale Securities | Total fixed maturities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:	474
Gain on sale of investments	5
Loss on Sale of Investments	$ 10
Predecessor | Available-for-sale Securities | Total fixed maturities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:		2,778
Gain on sale of investments		8
Loss on Sale of Investments		$ 43

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Investments:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2019 - $21,908; December 31, 2018 - $22,219)	$ 21,605	$ 21,109
Equity securities, at fair value (cost: March 31, 2019 - $1,226; December 31, 2018 - $1,526)	1,171	1,382
Derivative investments	305	97
Mortgage loans	674	667
Other invested assets	755	662
Total investments	24,510	23,917
Cash and cash equivalents	1,357	571
Accrued investment income	238	216
Funds withheld for reinsurance receivables, at fair value	837	757
Reinsurance recoverable	3,113	3,190
Intangibles, net	1,421	1,359
Deferred tax assets, net	283	343
Goodwill	467	467
Other assets	220	125
Total assets	32,446	30,945
LIABILITIES AND SHAREHOLDERS' EQUITY
Contractholder funds	23,881	23,387
Future policy benefits, including $797 and $725 at fair value at March 31, 2019 and December 31, 2018, respectively	4,677	4,641
Funds Held under Reinsurance Agreements, Liability	653	722
Liability for policy and contract claims	70	64
Debt	541	541
Other liabilities	873	700
Total liabilities	30,695	30,055
Commitments and contingencies (Note 12)
Shareholders' equity:
Preferred stock ($.0001 par value, 100,000,000 shares authorized, 406,510 and 399,033 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively)	0	0
Common stock ($.0001 par value, 800,000,000 shares authorized, 221,660,974 and 221,660,974 issued and outstanding at March 31, 2019 and December 31, 2018, respectively)	0	0
Additional paid-in capital	2,007	1,998
Retained earnings (Accumulated deficit)	(6)	(167)
Accumulated other comprehensive income (loss)	(216)	(937)
Treasury Stock, Value	34	4
Total shareholders' equity	1,751	890
Total liabilities and shareholders' equity	$ 32,446	$ 30,945

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Fixed maturity securities, available-for-sale, at fair value (amortized cost)	$ 21,908	$ 22,219
Equity securities, available-for-sale, at fair value (amortized cost)	1,226	1,526
Future policy benefits. at fair value	$ 797	$ 725
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred Stock, shares issued (in shares)	406,510	399,033
Preferred Stock, shares outstanding (in shares)	406,510	399,033
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	800,000,000	800,000,000
Common stock, shares issued (in shares)	211,660,974	211,660,974
Common stock, shares outstanding (in shares)	211,660,974	211,660,974
Treasury Stock, shares (in shares)	0	0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues:
Premiums	$ 16
Net investment income	289
Net investment gains (losses)	240	$ (191)
Insurance and investment product fees and other	55
Total revenues	600
Benefits and expenses:
Benefits and other changes in policy reserves	339
Acquisition and operating expenses, net of deferrals	44
Amortization of intangibles	29
Total benefits and expenses	412
Operating income	188
Interest expense	(8)
Income (loss) before income taxes	180
Income tax expense	(9)
Net income (loss)	171	65
Less Preferred stock dividend	8	7
Net income (loss) available to common shareholders	$ 163	$ 58
Net income per common share
Basic (in USD per share)	$ 0.74
Diluted (in USD per share)	$ 0.74
Weighted average common shares used in computing net income per common share:
Basic (in shares)	219,645,679
Diluted (in shares)	219,681,528
Cash dividend per common share (in dollars per share)	$ 0.01	$ 0
Total other-than-temporary impairments	$ (2)
Portion of other-than-temporary impairments included in other comprehensive income	0
Net other-than-temporary impairments	(2)	$ (2)
Gains (losses) on derivatives and embedded derivatives	164
Other investment gains (losses)	78
Net investment gains (losses)	$ 240	(191)
Predecessor
Revenues:
Premiums		18
Net investment income		263
Net investment gains (losses)		(191)
Insurance and investment product fees and other		48
Total revenues		138
Benefits and expenses:
Benefits and other changes in policy reserves		(39)
Acquisition and operating expenses, net of deferrals		40
Amortization of intangibles		27
Total benefits and expenses		28
Operating income		110
Interest expense		(6)
Income (loss) before income taxes		104
Income tax expense		(39)
Net income (loss)		65
Less Preferred stock dividend		$ 7
Net income per common share
Basic (in USD per share)		$ 0.27
Diluted (in USD per share)		$ 0.27
Weighted average common shares used in computing net income per common share:
Basic (in shares)		214,370,000
Diluted (in shares)		214,370,000
Total other-than-temporary impairments		$ (2)
Portion of other-than-temporary impairments included in other comprehensive income		0
Net other-than-temporary impairments		(2)
Gains (losses) on derivatives and embedded derivatives		(145)
Other investment gains (losses)		(44)
Net investment gains (losses)		$ (191)

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net income (loss)	$ 171	$ 65
Unrealized investment gains/losses:
Net change in unrealized gains/losses on investments	724	(359)
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(3)	2
Net changes to derive comprehensive income (loss) for the period	721	(357)
Comprehensive income (loss), net of tax	$ 892	(292)
Predecessor
Net income (loss)		$ 65

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock [Member]	Common Stock	Common StockAdditional Paid-in Capital	Common StockRetained Earnings (Accumulated Deficit)	Preferred Stock	Preferred StockAdditional Paid-in Capital	Preferred StockRetained Earnings (Accumulated Deficit)
Beginning Balance at Dec. 31, 2017	$ 1,963	$ 0	$ 0	$ 2,037	$ (149)	$ 75	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	(5)			2	(7)
Net income (loss) | Predecessor	65
Net income (loss)	65				65
Unrealized investment losses, net	(359)					(359)
Ending Balance at Mar. 31, 2018	1,666	0	0	2,039	(95)	(278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	2
Cumulative Effect of New Accounting Principle in Period of Adoption					(4)	4
Stock Repurchased During Period, Value	(30)						(30)
Beginning Balance at Dec. 31, 2018	890	0	0	1,998	(167)	(937)	(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends								$ (2)	$ 0	$ (2)	$ 0	$ 8	$ (8)
Net income (loss)	171				171
Unrealized investment losses, net	724					724
Ending Balance at Mar. 31, 2019	1,751	$ 0	$ 0	2,007	$ (6)	(216)	$ (34)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(3)					$ (3)
Stock Issued During Period, Value, Stock Dividend	$ 1			$ 1

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income (loss)	$ 171	$ 65
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation	1	0
Amortization	4	15
Increase (Decrease) in Deferred Income Taxes	5	12
Interest credited/index credits to contractholder account balances	308	(30)
Net recognized losses (gains) on investments and derivatives	(240)	191
Charges assessed to contractholders for mortality and administration	(32)	(38)
Intangibles, net	(90)	(55)
Changes in operating assets and liabilities:
Reinsurance recoverable	(16)	(8)
Future policy benefits	36	(40)
Funds withheld for reinsurers	(129)	(12)
Collateral (returned) posted	141	(145)
Other assets and other liabilities	(63)	10
Net cash provided by (used in) operating activities	96	(35)
Cash flows from investing activities:
Proceeds from mortgage loans	4	20
Costs of mortgage loans	12	0
Capital expenditures	(1)	(3)
Contingent purchase price payment	0	(30)
Net cash provided by (used in) investing activities	404	(377)
Cash flows from financing activities:
Treasury stock	30	0
Draw on revolving credit facility	0	30
Dividends paid	(2)	0
Contractholder account deposits	1,225	959
Contractholder account withdrawals	(907)	(635)
Net cash provided by (used in) financing activities	286	354
Change in cash & cash equivalents	786	(58)
Cash & cash equivalents, beginning of period	571
Cash & cash equivalents, end of period	1,357	1,157
Supplemental disclosures of cash flow information:
Interest paid	0	2
Income taxes (refunded) paid	(1)	(30)
Deferred sales inducements	35	26
Available-for-sale Securities
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	962	3,286
Cost of available-for-sale investments:	(421)	(3,699)
Derivative and other
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	44	143
Cost of available-for-sale investments:	$ (172)	(94)
Predecessor
Cash flows from operating activities:
Net income (loss)		$ 65

Basis of Presentation and Natur

Basis of Presentation and Nature of Business	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Nature of Business	Basis of Presentation FGL Holdings (the “Company”), a Cayman Islands exempted company, markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia. F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability, provides a platform for non-affiliated international business. Front Street Re Cayman Ltd (“FSRC”), an exempted company incorporated in the Cayman Islands with limited liability, has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of FGL Holdings and parties to reinsurance transactions. The accompanying unaudited condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X, for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. Therefore, the information contained in the Notes to Consolidated Financial Statements included in the Company's 2018 Form 10-K, should be read in connection with the reading of these interim unaudited condensed consolidated financial statements. In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Operating results for the three months ended March 31, 2019 , are not necessarily indicative of the results that may be expected for the full year ending December 31, 2019 . Amounts reclassified out of other comprehensive income are reflected in net investment gains in the unaudited Condensed Consolidated Statements of Operations. Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.

Significant Accounting Policies

Significant Accounting Policies and Practices	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Significant Accounting Policies and Practices	Adoption of New Accounting Pronouncements Premium Amortization on Purchased Callable Debt Securities In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities) , effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date (as under current GAAP). The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update should be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Amendments to Lease Accounting In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842) ), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update will: • require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less • create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance • not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02 • provide additional guidance on separating the lease components from the nonlease components of a contract • require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases • include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements The amendments are required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company has adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Future Accounting Pronouncements Accounting pronouncements that will impact the Company in future periods have been disclosed in the Company’s 2018 Form 10-K. There have not been any additional accounting pronouncements issued during the quarter ended March 31, 2019 that are expected to impact the Company. The following two pronouncements were discussed in our 2018 Form 10-K but have been included below so as to provide an update on the Company’s status of adoption. New Credit Loss Standard In June 2016, the FASB issued new guidance (ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments) , effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Notable amendments in this update will change the accounting for impairment of most financial assets and certain other instruments in the following ways: • financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset at purchase • credit losses relating to AFS fixed maturity securities will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value • the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount • disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due The amendments in this ASU may be early adopted during any interim or annual period beginning after December 15, 2018, however the Company has elected not to. The Company has identified the material asset classes impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply with the new guidance. The Company has developed a project plan to complete our adoption of this new standard, and is evaluating the impact of the new guidance on its consolidated financial statements. Long-Duration Contracts In August 2018, the FASB issued new guidance (ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts) , effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update: • assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations • the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income • market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income • deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts • deferred acquisition costs must be written off for unexpected contract terminations • disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

Significant Risks and Uncertain

Significant Risks and Uncertainties	3 Months Ended
	Mar. 31, 2019
Risks and Uncertainties [Abstract]
Significant Risks and Uncertainties	Significant Risks and Uncertainties Federal Regulation In April 2016, the Department of Labor (“DOL”) issued the “fiduciary” rule which could have had a material impact on the Company, its products, distribution, and business model. The rule provided that persons who render investment advice for a fee or other compensation with respect to an employer plan or individual retirement account ("IRA") are fiduciaries of that plan or IRA and would have expanded the definition of fiduciary under ERISA to apply to commissioned insurance agents who sell the Company’s IRA products. On June 21, 2018, the United States Court of Appeals for the Fifth Circuit formally vacated the DOL fiduciary rule in total when it issued its mandate following the court’s decision on March 15, 2018, in U.S. Chamber of Commerce v. U.S. Department of Labor , 885 F.3d 360 (5th Cir. 2018). Management will continue to monitor for potential action by state officials or the SEC to implement rules similar to the vacated DOL rule. Use of Estimates and Assumptions The preparation of the Company's unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used. Concentrations of Financial Instruments As of March 31, 2019 and December 31, 2018 , the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the Banking industry with a fair value of $2,348 or 10% and $2,491 or 10% , respectively, of the invested assets portfolio and an amortized cost of $2,416 and $2,691 , respectively. As of March 31, 2019 , the Company’s holdings in this industry include investments in 107 different issuers with the top ten investments accounting for 35% of the total holdings in this industry. As of March 31, 2019 the Company had no investments in issuers that exceeded 10% of shareholders' equity. As of December 31, 2018 , the Company had 16 investments in issuers that exceeded 10% of shareholders' equity, with a total fair value of $1,634 or 7% of the invested assets portfolio: JP Morgan Chase & Co, Metropolitan Transportation Authority (NY), AT&T Inc, HSBC Holdings, Wells Fargo & Company, General Motors Co, Nationwide Mutual Insurance Company, Goldman Sachs Group Inc, United Mexican States, Energy Transfer Partners, Prudential Financial Inc, Citigroup Inc, HP Enterprise Co, Viacom Inc, Kinder Morgan Energy Partners, and Fuel Trust. The Company's largest concentration in any single issuer as of March 31, 2019 and December 31, 2018 was AT&T and JP Morgan Chase & Co , respectively, with a total fair value of $124 or 1% and $115 or 1% of the invested assets portfolio, respectively. Concentrations of Financial and Capital Markets Risk The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company expects to continue to face challenges and uncertainties that could adversely affect its results of operations and financial condition. The Company attempts to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset backed securities. The Company’s exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will increase the net unrealized loss position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. Management believes this risk is mitigated to some extent by surrender charge protection provided by the Company’s products. Concentration of Reinsurance Risk The Company has a significant concentration of reinsurance risk with third party reinsurers, Wilton Reassurance Company (“Wilton Re”) and Kubera Insurance (SAC) Ltd. acting in respect of Annuity Reinsurance Cell A1 ("Kubera") that could have a material impact on the Company’s financial position in the event that Wilton Re or Kubera fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly-owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA issuer credit rating from Standard & Poor's Ratings Services ("S&P") as of March 31, 2019 . Kubera is not rated, however, management has attempted to mitigate the risk of non-performance through the funds withheld arrangement. As of March 31, 2019 , the net amount recoverable from Wilton Re was $1,541 and the net amount recoverable from Kubera was $681 . The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar activities and economic characteristics of reinsurers to attempt to reduce the risk of default by such reinsurers. Wilton Re and Kubera are current on all amounts due as of March 31, 2019 . On March 6, 2019, Scottish Re (U.S.), Inc. (“SRUS”), a Delaware domestic life and health reinsurer of FGL Insurance, was ordered into receivership for purposes rehabilitation. As of March 31, 2019 , the net amount recoverable from SRUS was $47 . The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

Investments

Investments	3 Months Ended
	Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]
Investments	1.25 1.00 - 1.25 March 31, 2019 LTV Ratios: Less than 50% $ 299 $ 6 $ 305 64 % $ 309 64 % 50% to 60% 163 — 163 34 % 165 34 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 473 $ 6 $ 479 100 % $ 485 100 % December 31, 2018 LTV Ratios: Less than 50% $ 296 $ 6 $ 302 63 % $ 302 63 % 50% to 60% 169 — 169 35 % 170 35 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 476 $ 6 $ 482 100 % $ 483 100 % (a) N/A - Current DSC ratio not available. The Company establishes a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. The Company believes that the LTV ratio is an indicator of the principal recovery risk for loans that default. A higher LTV ratio will result in a higher allowance. The Company believes that the DSC ratio is an indicator of default risk on loans. A higher DSC ratio will result in a lower allowance. The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At March 31, 2019 and December 31, 2018 , the Company had no CMLs that were delinquent in principal or interest payments. Mortgage loan workouts, refinances or restructures that are classified as troubled debt restructurings ("TDRs") are individually evaluated and measured for impairment. As of March 31, 2019 and December 31, 2018 , our CML portfolio had no impairments, modifications or TDRs. Residential Mortgage Loans Residential mortgage loans ("RMLs") represented approximately 1% of the Company’s total investments as of March 31, 2019 and December 31, 2018 . The Company's residential mortgage loans are closed end, amortizing loans. 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables: March 31, 2019 US State: Unpaid Principal Balance % of Total Illinois $ 29 15 % Florida 25 13 % South Carolina 24 13 % All Other States (a) 112 59 % Total mortgage loans $ 190 100 % (a) The individual concentration of each state is less than 9% as of March 31, 2019 . December 31, 2018 US State: Unpaid Principal Balance % of Total Florida $ 25 14 % Illinois 24 13 % New Jersey 17 9 % All Other States (a) 114 64 % Total mortgage loans $ 180 100 % (a) The individual concentration of each state is less than 9% as of December 31, 2018 . Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due and/or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at March 31, 2019 and December 31, 2018 , respectively, was as follows: March 31, 2019 December 31, 2018 Performance indicators: Carrying Value % of Total Carrying Value % of Total Performing $ 195 100 % $ 185 100 % Non-performing — — % — — % Total residential mortgage loans, gross of valuation allowance $ 195 100 % $ 185 100 % Allowance for loan loss — — % — — % Total residential mortgage loans $ 195 100 % $ 185 100 % Net Investment Income The major sources of “Net investment income” on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended March 31, 2019 March 31, 2018 Fixed maturity securities, available-for-sale $ 265 $ 242 Equity securities 21 10 Mortgage loans 7 7 Invested cash and short-term investments 3 3 Funds withheld 8 7 Limited partnerships 8 3 Other investments 5 1 Gross investment income 317 273 Investment expense (28 ) (10 ) Net investment income $ 289 $ 263 Net Investment Gains (Losses) Details underlying “Net investment gains (losses)” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended March 31, 2019 March 31, 2018 Net realized gains (losses) on fixed maturity available-for-sale securities $ (3 ) $ (37 ) Net realized/unrealized gains (losses) on equity securities 78 (6 ) Realized gains (losses) on other invested assets 1 (3 ) Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments (26 ) 11 Unrealized gains (losses) on certain derivative instruments 190 (135 ) Change in fair value of reinsurance related embedded derivatives (a) (3 ) (21 ) Change in fair value of other derivatives and embedded derivatives 3 — Realized gains (losses) on derivatives and embedded derivatives 164 (145 ) Net investment gains (losses) $ 240 $ (191 ) (a) Change in fair value of reinsurance related embedded derivatives is due to F&G Re and FSRC unaffiliated third party business. The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows: Three months ended March 31, 2019 March 31, 2018 Proceeds $ 474 $ 2,778 Gross gains 5 8 Gross losses (10 ) (43 ) Unconsolidated Variable Interest Entities FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. These VIEs are not consolidated in the Company’s financial statements for the following reasons: 1) FGL Insurance either does not control or does not have any voting rights or notice rights; 2) the Company does not have any substantive rights to remove the investment manager; and 3) the Company was not involved in the design of the investment. These characteristics indicate that FGL Insurance lacks the ability to direct the activities, or otherwise exert control, of the VIEs and is not considered the primary beneficiary of them. The Company previously executed a commitment of $75 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power. The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund June 2019. The Company has funded $54 as of March 31, 2019 . The Company invests in various limited partnerships as a passive investor. These investments are in corporate credit and real estate debt strategies that have a current income bias. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s consolidated balance sheet. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of March 31, 2019 , the Company's maximum exposure to loss was $595 in recorded carrying value and $1,093 in unfunded commitments." id="sjs-B4">Investments The Company’s fixed maturity securities investments have been designated as available-for-sale and are carried at fair value with unrealized gains and losses included in AOCI, net of associated adjustments for deferred acquisition costs ("DAC"), value of business acquired ("VOBA"), deferred sales inducements ("DSI"), unearned revenue ("UREV"), and deferred income taxes. The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at March 31, 2019 and December 31, 2018 are summarized as follows: March 31, 2019 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for sale securities Asset-backed securities $ 5,033 $ 23 $ (82 ) $ 4,974 $ 4,974 Commercial mortgage-backed securities 2,596 60 (9 ) 2,647 2,647 Corporates 10,886 60 (356 ) 10,590 10,590 Hybrids 988 6 (33 ) 961 961 Municipals 1,211 16 (10 ) 1,217 1,217 Residential mortgage-backed securities 1,000 27 (5 ) 1,022 1,022 U.S. Government 56 — — 56 56 Foreign Governments 138 2 (2 ) 138 138 Total available-for-sale securities 21,908 194 (497 ) 21,605 21,605 Equity securities 1,226 3 (58 ) 1,171 1,171 Derivative investments 318 74 (87 ) 305 305 Commercial mortgage loans 479 — — 485 479 Residential mortgage loans 195 — — 199 195 Other invested assets 759 — (4 ) 744 755 Total investments $ 24,885 $ 271 $ (646 ) $ 24,509 $ 24,510 December 31, 2018 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for sale securities Asset-backed securities $ 4,954 $ 15 $ (137 ) $ 4,832 $ 4,832 Commercial mortgage-backed securities 2,568 9 (40 ) 2,537 2,537 Corporates 11,213 16 (848 ) 10,381 10,381 Hybrids 992 — (91 ) 901 901 Municipals 1,216 3 (32 ) 1,187 1,187 Residential mortgage-backed securities 1,027 12 (8 ) 1,031 1,031 U.S. Government 120 — (1 ) 119 119 Foreign Governments 129 — (8 ) 121 121 Total available-for-sale securities 22,219 55 (1,165 ) 21,109 21,109 Equity securities 1,526 1 (145 ) 1,382 1,382 Derivative investments 330 2 (235 ) 97 97 Commercial mortgage loans 482 — — 483 482 Residential mortgage loans 185 — — 187 185 Other invested assets 662 — — 651 662 Total investments $ 25,404 $ 58 $ (1,545 ) $ 23,909 $ 23,917 Included in AOCI were cumulative gross unrealized gains of $0 and gross unrealized losses of $0 related to the non-credit portion of other-than-temporary-impairments ("OTTI") on non-agency residential mortgage backed securities ("RMBS") for both March 31, 2019 and December 31, 2018 . Securities held on deposit with various state regulatory authorities had a fair value of $16,135 and $19,930 at March 31, 2019 and December 31, 2018 , respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the legal reserve. At March 31, 2019 and December 31, 2018 , the Company held no material investments that were non-income producing for a period greater than twelve months. In accordance with the Company's FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $1,186 and $1,401 at March 31, 2019 and December 31, 2018 , respectively. The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations. March 31, 2019 Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 160 $ 160 Due after one year through five years 758 749 Due after five years through ten years 2,080 2,059 Due after ten years 10,281 9,994 Subtotal 13,279 12,962 Other securities which provide for periodic payments: Asset-backed securities 5,033 4,974 Commercial mortgage-backed securities 2,596 2,647 Residential mortgage-backed securities 1,000 1,022 Subtotal 8,629 8,643 Total fixed maturity available-for-sale securities $ 21,908 $ 21,605 The Company's available-for-sale securities with unrealized losses are reviewed for potential OTTI. For factors considered in evaluating whether a decline in value is other-than-temporary, please refer to “Note 2. Significant Accounting Policies and Practices" to the Company’s 2018 Form 10-K. The Company analyzes its ability to recover the amortized cost by comparing the net present value of cash flows expected to be collected with the amortized cost of the security. Additionally, the Company considers other factors, including, but not limited to: whether the issuer is currently meeting its financial obligations and its ability to continue to meet these obligations, its existing cash available, and its access to additional available capital. For mortgage-backed and asset-backed securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions, based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. For structured securities, the payment priority within the tranche structure is also considered. For all other fixed maturity securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. If the net present value is less than the amortized cost of the investment, an OTTI is recognized. Based on the results of our process for evaluating available-for-sale securities in unrealized loss positions for OTTI, as discussed above, the Company determined the unrealized losses as of March 31, 2019 decreased due to lower interest rates during the first quarter in conjunction with tighter credit spreads over Treasuries. The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows: March 31, 2019 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 2,696 $ (63 ) $ 886 $ (19 ) $ 3,582 $ (82 ) Commercial mortgage-backed securities 243 (4 ) 250 (5 ) 493 (9 ) Corporates 684 (15 ) 7,227 (341 ) 7,911 (356 ) Hybrids 333 (14 ) 343 (19 ) 676 (33 ) Municipals 45 — 482 (10 ) 527 (10 ) Residential mortgage-backed securities 41 (1 ) 238 (4 ) 279 (5 ) U.S. Government — — 50 — 50 — Foreign Government — — 81 (2 ) 81 (2 ) Total available-for-sale securities $ 4,042 $ (97 ) $ 9,557 $ (400 ) $ 13,599 $ (497 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 468 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 1164 Total number of available-for-sale securities in an unrealized loss position 1,632 December 31, 2018 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 2,924 $ (116 ) $ 643 $ (21 ) $ 3,567 $ (137 ) Commercial mortgage-backed securities 1,466 (34 ) 262 (6 ) 1,728 (40 ) Corporates 8,016 (772 ) 1,465 (76 ) 9,481 (848 ) Hybrids 858 (90 ) 7 (1 ) 865 (91 ) Municipals 850 (27 ) 172 (5 ) 1,022 (32 ) Residential mortgage-backed securities 139 (3 ) 190 (5 ) 329 (8 ) U.S. Government 69 — 50 (1 ) 119 (1 ) Foreign Government 47 (3 ) 68 (5 ) 115 (8 ) Total available-for-sale securities $ 14,369 $ (1,045 ) $ 2,857 $ (120 ) $ 17,226 $ (1,165 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,551 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 556 Total number of available-for-sale securities in an unrealized loss position 2,107 At March 31, 2019 and December 31, 2018 , securities in an unrealized loss position were primarily concentrated in corporate debt. At March 31, 2019 and December 31, 2018 , securities with a fair value of $40 and $132 , respectively, had an unrealized loss greater than 20% of amortized cost (excluding U.S. Government and U.S. Government sponsored agency securities), which were insignificant to the carrying value of all investments, respectively. The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the three months ended March 31, 2019 and 2018 , for which a portion of the OTTI was recognized in AOCI: Three months ended March 31, 2019 March 31, 2018 Beginning balance $ — $ — Increases attributable to credit losses on securities: OTTI was previously recognized — — OTTI was not previously recognized — — Ending balance $ — $ — The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the three months ended March 31, 2019 and 2018 : Three months ended March 31, 2019 March 31, 2018 Credit impairment losses in operations $ (2 ) $ (2 ) Change-of-intent losses in operations — — Amortized cost 1 — Fair value 1 — Non-credit losses in other comprehensive income for investments which experienced OTTI — — Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows: Three months ended March 31, 2019 March 31, 2018 Corporates (2 ) (2 ) Total $ (2 ) $ (2 ) Mortgage Loans The Company's mortgage loans are collateralized by commercial and residential properties. Commercial Mortgage Loans Commercial mortgage loans ("CMLs") represented approximately 2% of the Company’s total investments as of March 31, 2019 and December 31, 2018 . The Company primarily invests in mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to attempt to reduce concentration risk. The Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: March 31, 2019 December 31, 2018 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: Hotel 21 4 % 21 4 % Industrial - General 37 8 % 37 8 % Industrial - Warehouse 20 4 % 20 4 % Multifamily 55 11 % 56 12 % Office 146 31 % 147 30 % Retail 200 42 % 201 42 % Total commercial mortgage loans, gross of valuation allowance $ 479 100 % $ 482 100 % Allowance for loan loss — — Total commercial mortgage loans $ 479 $ 482 U.S. Region: East North Central $ 97 20 % $ 98 20 % East South Central 19 4 % 19 4 % Middle Atlantic 78 16 % 79 17 % Mountain 65 14 % 65 13 % New England 10 2 % 10 2 % Pacific 115 24 % 116 24 % South Atlantic 57 12 % 57 12 % West North Central 13 3 % 13 3 % West South Central 25 5 % 25 5 % Total commercial mortgage loans, gross of valuation allowance $ 479 100 % $ 482 100 % Allowance for loan loss — — Total commercial mortgage loans $ 479 $ 482 All of the Company's investments in CMLs had a loan-to-value ("LTV") ratio of less than 75% at March 31, 2019 and December 31, 2018 , as measured at inception of the loans unless otherwise updated. As of March 31, 2019 , all CMLs are current and have not experienced credit or other events which would require the recording of an impairment loss. LTV and DSC ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation. The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at March 31, 2019 and December 31, 2018 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 March 31, 2019 LTV Ratios: Less than 50% $ 299 $ 6 $ 305 64 % $ 309 64 % 50% to 60% 163 — 163 34 % 165 34 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 473 $ 6 $ 479 100 % $ 485 100 % December 31, 2018 LTV Ratios: Less than 50% $ 296 $ 6 $ 302 63 % $ 302 63 % 50% to 60% 169 — 169 35 % 170 35 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 476 $ 6 $ 482 100 % $ 483 100 % (a) N/A - Current DSC ratio not available. The Company establishes a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. The Company believes that the LTV ratio is an indicator of the principal recovery risk for loans that default. A higher LTV ratio will result in a higher allowance. The Company believes that the DSC ratio is an indicator of default risk on loans. A higher DSC ratio will result in a lower allowance. The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At March 31, 2019 and December 31, 2018 , the Company had no CMLs that were delinquent in principal or interest payments. Mortgage loan workouts, refinances or restructures that are classified as troubled debt restructurings ("TDRs") are individually evaluated and measured for impairment. As of March 31, 2019 and December 31, 2018 , our CML portfolio had no impairments, modifications or TDRs. Residential Mortgage Loans Residential mortgage loans ("RMLs") represented approximately 1% of the Company’s total investments as of March 31, 2019 and December 31, 2018 . The Company's residential mortgage loans are closed end, amortizing loans. 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables: March 31, 2019 US State: Unpaid Principal Balance % of Total Illinois $ 29 15 % Florida 25 13 % South Carolina 24 13 % All Other States (a) 112 59 % Total mortgage loans $ 190 100 % (a) The individual concentration of each state is less than 9% as of March 31, 2019 . December 31, 2018 US State: Unpaid Principal Balance % of Total Florida $ 25 14 % Illinois 24 13 % New Jersey 17 9 % All Other States (a) 114 64 % Total mortgage loans $ 180 100 % (a) The individual concentration of each state is less than 9% as of December 31, 2018 . Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due and/or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at March 31, 2019 and December 31, 2018 , respectively, was as follows: March 31, 2019 December 31, 2018 Performance indicators: Carrying Value % of Total Carrying Value % of Total Performing $ 195 100 % $ 185 100 % Non-performing — — % — — % Total residential mortgage loans, gross of valuation allowance $ 195 100 % $ 185 100 % Allowance for loan loss — — % — — % Total residential mortgage loans $ 195 100 % $ 185 100 % Net Investment Income The major sources of “Net investment income” on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended March 31, 2019 March 31, 2018 Fixed maturity securities, available-for-sale $ 265 $ 242 Equity securities 21 10 Mortgage loans 7 7 Invested cash and short-term investments 3 3 Funds withheld 8 7 Limited partnerships 8 3 Other investments 5 1 Gross investment income 317 273 Investment expense (28 ) (10 ) Net investment income $ 289 $ 263 Net Investment Gains (Losses) Details underlying “Net investment gains (losses)” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended March 31, 2019 March 31, 2018 Net realized gains (losses) on fixed maturity available-for-sale securities $ (3 ) $ (37 ) Net realized/unrealized gains (losses) on equity securities 78 (6 ) Realized gains (losses) on other invested assets 1 (3 ) Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments (26 ) 11 Unrealized gains (losses) on certain derivative instruments 190 (135 ) Change in fair value of reinsurance related embedded derivatives (a) (3 ) (21 ) Change in fair value of other derivatives and embedded derivatives 3 — Realized gains (losses) on derivatives and embedded derivatives 164 (145 ) Net investment gains (losses) $ 240 $ (191 ) (a) Change in fair value of reinsurance related embedded derivatives is due to F&G Re and FSRC unaffiliated third party business. The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows: Three months ended March 31, 2019 March 31, 2018 Proceeds $ 474 $ 2,778 Gross gains 5 8 Gross losses (10 ) (43 ) Unconsolidated Variable Interest Entities FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. These VIEs are not consolidated in the Company’s financial statements for the following reasons: 1) FGL Insurance either does not control or does not have any voting rights or notice rights; 2) the Company does not have any substantive rights to remove the investment manager; and 3) the Company was not involved in the design of the investment. These characteristics indicate that FGL Insurance lacks the ability to direct the activities, or otherwise exert control, of the VIEs and is not considered the primary beneficiary of them. The Company previously executed a commitment of $75 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power. The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund June 2019. The Company has funded $54 as of March 31, 2019 . The Company invests in various limited partnerships as a passive investor. These investments are in corporate credit and real estate debt strategies that have a current income bias. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s consolidated balance sheet. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of March 31, 2019 , the Company's maximum exposure to loss was $595 in recorded carrying value and $1,093 in unfunded commitments.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows: March 31, 2019 December 31, 2018 Assets: Derivative investments: Call options $ 304 $ 97 Futures contracts 1 — Other invested assets: Other derivatives and embedded derivatives 17 14 $ 322 $ 111 Liabilities: Contractholder funds: FIA embedded derivative $ 2,720 $ 2,476 Other liabilities: Preferred shares reimbursement feature embedded derivative 27 29 $ 2,747 $ 2,505 The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows: Three months ended March 31, 2019 March 31, 2018 Revenues: Net investment gains (losses): Call options $ 154 $ (122 ) Futures contracts 8 (2 ) Foreign currency forward 2 — Other derivatives and embedded derivatives 3 — Reinsurance related embedded derivatives (3 ) (21 ) Total net investment gains (losses) $ 164 $ (145 ) Benefits and other changes in policy reserves: FIA embedded derivatives $ 244 $ (98 ) Acquisition and operating expenses, net of deferrals: Preferred shares reimbursement feature embedded derivative $ 2 $ (1 ) Additional Disclosures Other Derivatives and Embedded Derivatives The Company holds a $35 fund-linked note issued by Nomura International Funding Pte. Ltd. The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund") of $11 which was based on the actual return of the fund. At March 31, 2019 , the fair value of the fund-linked note and embedded derivative were $27 and $17 , respectively. At December 31, 2018, the fair value of the fund-linked note and embedded derivative were $26 and $14 , respectively. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale". Fixed Index Annuity ("FIA") Embedded Derivative and Call Options and Futures The Company has FIA Contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under GAAP. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in the accompanying Condensed Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in the unaudited Condensed Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments". The Company purchases derivatives consisting of a combination of call options and futures contracts on the applicable market indices to fund the index credits due to FIA contractholders. The call options are one , two , three , and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the index policies, the index used to compute the interest credit is reset and the Company purchases new one , two , three , or five year call options to fund the next index credit. The Company manages the cost of these purchases through the terms of its FIA contracts, which permit the Company to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA embedded derivative related to index performance. The call options and futures contracts are marked to fair value with the change in fair value included as a component of “Net investment gains (losses).” The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument term or upon early termination and the changes in fair value of open positions. Other market exposures are hedged periodically depending on market conditions and the Company’s risk tolerance. The Company’s FIA hedging strategy economically hedges the equity returns and exposes the Company to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. The Company uses a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. The Company intends to continue to adjust the hedging strategy as market conditions and the Company’s risk tolerance change. Preferred Equity Remarketing Reimbursement Embedded Derivative Liability On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years. From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is held at fair value within “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option. Changes in fair value of this derivative are recognized within “Acquisition and operating expenses, net of deferrals” in the accompanying unaudited Condensed Consolidated Statements of Operations. Credit Risk The Company is exposed to credit loss in the event of non-performance by its counterparties on the call options and reflects assumptions regarding this non-performance risk in the fair value of the call options. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table: March 31, 2019 Counterparty Credit Rating (Fitch/Moody's/S&P) (a) Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 3,496 $ 70 $ 25 $ 45 Deutsche Bank A-/A3/BBB+ 1,151 14 14 — Morgan Stanley */A1/A+ 1,657 25 24 1 Barclay's Bank A+/A2/A 2,752 79 61 18 Canadian Imperial Bank of Commerce */Aa2/A+ 1,430 41 29 12 Wells Fargo A+/A2/A- 2,034 58 56 2 Goldman Sachs A/A3/BBB+ 1,030 17 16 1 Total $ 13,550 $ 304 $ 225 $ 79 December 31, 2018 Counterparty Credit Rating Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 3,952 $ 25 $ — $ 25 Deutsche Bank A-/A3/BBB+ 1,327 5 6 (1 ) Morgan Stanley */A1/A+ 1,648 9 6 3 Barclay's Bank A+/A2/A 2,205 27 20 7 Canadian Imperial Bank of Commerce */Aa2/A+ 1,716 11 8 3 Wells Fargo A+/A2/A- 1,635 17 16 1 Goldman Sachs A/A3/BBB+ 647 3 3 — Total $ 13,130 $ 97 $ 59 $ 38 (a) An * represents credit ratings that were not available. Collateral Agreements The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open option contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying option contracts. The Company's current rating doesn't allow any counterparty the right to terminate ISDA agreements. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, this threshold is set to zero. As of March 31, 2019 and December 31, 2018 , counterparties posted $225 and $59 of collateral, respectively, of which $200 and $59 is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the Condensed Consolidated Balance Sheets . The remaining $25 and $0 of non-cash collateral was held by a third-party custodian and may not be sold or re-pledged, except in the event of default, and, therefore, is not included in the Company's Condensed Consolidated Balance Sheets at March 31, 2019 and December 31, 2018 , respectively. This collateral generally consists of U.S. treasury bonds and mortgage-backed securities. Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $79 and $38 at March 31, 2019 and December 31, 2018 , respectively. The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes. The Company reinvests derivative cash collateral to reduce the interest cost. Cash collateral is invested in short term Treasury securities and A1/P1 commercial paper which are included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets. The Company held 774 and 664 futures contracts at March 31, 2019 and December 31, 2018 , respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $4 and $3 at March 31, 2019 and December 31, 2018 , respectively.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows: Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date. Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves. Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources. The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows: March 31, 2019 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 1,357 $ — $ — $ 1,357 $ 1,357 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,466 508 4,974 4,974 Commercial mortgage-backed securities — 2,579 68 2,647 2,647 Corporates — 9,381 1,209 10,590 10,590 Hybrids 277 674 10 961 961 Municipals — 1,179 38 1,217 1,217 Residential mortgage-backed securities — 403 619 1,022 1,022 U.S. Government 51 5 — 56 56 Foreign Governments — 122 16 138 138 Equity securities 441 657 20 1,118 1,118 Derivative investments 1 304 — 305 305 Other invested assets — — 41 41 41 Funds withheld for reinsurance receivables, at fair value 161 664 7 832 832 Total financial assets at fair value $ 2,288 $ 20,434 $ 2,536 $ 25,258 $ 25,258 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds — — 2,720 2,720 2,720 Preferred shares reimbursement feature embedded derivative — — 27 27 27 Fair value of future policy benefits — — 797 797 797 Total financial liabilities at fair value $ — $ — $ 3,544 $ 3,544 $ 3,544 December 31, 2018 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 571 $ — $ — $ 571 $ 571 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,388 444 4,832 4,832 Commercial mortgage-backed securities — 2,470 67 2,537 2,537 Corporates — 9,150 1,231 10,381 10,381 Hybrids 265 626 10 901 901 Municipals — 1,150 37 1,187 1,187 Residential mortgage-backed securities — 417 614 1,031 1,031 U.S. Government 114 5 — 119 119 Foreign Governments — 105 16 121 121 Equity securities 454 874 4 1,332 1,332 Derivative investments — 97 — 97 97 Other invested assets — — 39 39 39 Funds withheld for reinsurance receivables, at fair value 169 576 4 749 749 Total financial assets at fair value $ 1,573 $ 19,858 $ 2,466 $ 23,897 $ 23,897 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ — $ — $ 2,476 $ 2,476 $ 2,476 Preferred shares reimbursement feature embedded derivative — — 29 29 29 Fair value of future policy benefits — — 725 725 725 Total financial liabilities at fair value $ — $ — $ 3,230 $ 3,230 $ 3,230 Valuation Methodologies Fixed Maturity Securities & Equity Securities The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met. For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant unobservable input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. Management believes the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. The Company has an equity investment in a private business development company which is not traded on an exchange or valued by other sources such as analytics or brokers. The Company based the fair value of this investment on an estimated net asset value provided by the investee. Management did not make any adjustments to this valuation. The fair value of the Company's investment in mutual funds is based on the net asset value published by the respective mutual fund and represents the value the Company would have received if it withdrew its investment on the balance sheet date. The Company did not adjust prices received from third parties as of March 31, 2019 or December 31, 2018 . However, the Company does analyze the third-party valuation methodologies and related inputs to perform assessments to determine the appropriate level within the fair value hierarchy. Derivative Financial Instruments The fair value of call option assets is based upon valuation pricing models, which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally, based on valuation pricing models which use market-observable inputs, including interest rates, yield curve volatilities, and other factors. The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements) which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the futures contract or entered into offsetting positions. These contracts are classified as Level 1. The fair value measurement of the FIA embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs. The market observable inputs are the market value of option and interest swap rates. The significant unobservable inputs are the mortality multiplier, surrender rates, non-performance spread and option costs. The mortality multiplier at March 31, 2019 and December 31, 2018 was applied to the Annuity 2000 mortality tables. Significant increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Significant increases or decreases in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input. The fair value of the Reimbursement Feature is determined using a Black Derman Toy model, incorporating the paid in kind dividend coupon, the Company's redemption option and the preferred shareholder's remarketing feature. The remarketing feature allows the shareholder to put the preferred shares to the Company for a value of par after five years and, if after a successful remarketing event the amount is less than 90% par, up to a maximum of 10% of liquidation price defined. Fair value of this derivative decreased $2 during the three months ended March 31, 2019 , due to changes in the credit spread. Other Invested Assets Fair value of the AnchorPath embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date. The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date. A Black-Scholes model determines the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model. The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease. FSRC and F&G Re Funds Withheld for Reinsurance Receivables and Future Policy Benefits FSRC and F&G Re elected to apply the Fair Value Option to account for its funds withheld receivables and future policy benefits liability related to its assumed reinsurance. FSRC and F&G Re measures the fair value of the Funds Withheld for Reinsurance Receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the Future Policy Benefits Reserve. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions (plus a risk margin, where applicable) and are consistent with market prices, where available. Risk margins are typically applied to non-observable, non-hedgeable market inputs such as long term volatility, mortality, morbidity, lapse, etc. The significant unobservable inputs used in the fair value measurement of the FSRC and F&G Re future policy benefit liability are undiscounted cash flows, non-performance risk spread and risk margin to reflect uncertainty. Undiscounted cash flows used in our March 31, 2019 discounted cash flow model equaled $1,152 . Increases or decreases in non-performance risk spread and risk margin to reflect uncertainty would result in a lower or higher fair value measurement, respectively. Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of March 31, 2019 and December 31, 2018 , are as follows: Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) March 31, 2019 March 31, 2019 Assets Asset-backed securities $ 489 Broker-quoted Offered quotes 97.50% - 105.17% (100.84%) Asset-backed securities 19 Third-Party Valuation Offered quotes 0.00% - 98.30% (28.44%) Commercial mortgage-backed securities 43 Broker-quoted Offered quotes 81.01% - 100.14% (87.90%) Commercial mortgage-backed securities 25 Matrix Pricing Quoted prices 121.01% - 121.01% (121.01%) Corporates 731 Broker-quoted Offered quotes 54.00% - 107.83% (99.49%) Corporates 478 Matrix Pricing Quoted prices 95.94% - 117.55% (101.67%) Hybrids 10 Matrix Pricing Quoted prices 98.84% - 98.84% (98.84%) Municipals 38 Broker-quoted Offered quotes 114.61% - 114.61% (114.61%) Residential mortgage-backed securities 619 Broker-quoted Offered quotes 92.52% - 103.81% (103.34%) Foreign governments 16 Broker-quoted Offered quotes 101.38% - 103.55% (102.06%) Equity securities 16 Broker-quoted Offered quotes 100.00% Equity securities (Salus preferred equity) 4 Income-Approach Yield 7.18% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 16 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables at fair value 6 Matrix pricing Quoted prices 100.00% Funds withheld for reinsurance receivables at fair value 1 Loan recovery value Recovery rate 14.00% Total $ 2,536 Liabilities Future policy benefits $ 797 Discounted cash flow Market value of option 0.88% - 6.95% (1.90%) Mortality multiplier 90.00% - 100.00% (100.00%) Surrender rates 0.65% - 40.00% (4.63%) Partial withdrawals 0.00% - 2.50% (0.93%) Non-performance spread 0.00% - 0.10% (0.03%) Option cost 1.14% - 4.58% (1.72%) Risk margin to reflect uncertainty 0.35% - 0.62% (0.44%) Morbidity risk margin 0.00% - 2.00% (0.17%) Derivatives: FIA embedded derivatives included in contractholder funds 2,720 Discounted cash flow Market value of option 0.00% - 32.37% (2.23%) SWAP rates 2.29% - 2.41% (2.34%) Mortality multiplier 80.00% - 80.00% (80.00%) Surrender rates 0.50% - 75.00% (5.86%) Partial withdrawals 1.00% - 2.50% (2.00%) Non-performance spread 0.25% - 0.25% (0.25%) Option cost 0.18% - 16.61% (2.16%) Preferred shares reimbursement feature embedded derivative 27 Black Derman Toy model Credit Spread 4.50% Yield Volatility 20.00% Total liabilities at fair value $ 3,544 Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2018 December 31, 2018 Assets Asset-backed securities $ 405 Broker-quoted Offered quotes 97.00% - 102.00% (99.77%) Asset-backed securities 24 Matrix Pricing Quoted prices 96.07% - 96.07% (96.07%) Asset-backed securities 15 Third-Party Valuation Offered quotes 0.00% - 99.29% (23.05%) Commercial mortgage-backed securities 43 Broker-quoted Offered quotes 77.12% - 100.08% (85.46%) Commercial mortgage-backed securities 24 Matrix Pricing Quoted prices 117.72% - 117.72% (117.72%) Corporates 577 Broker-quoted Offered quotes 74.63% - 104.62% (97.80%) Corporates 654 Matrix Pricing Quoted prices 91.74% - 113.25% (98.86%) Hybrids 10 Matrix Pricing Quoted prices 96.60% - 96.60% (96.60%) Municipals 37 Broker-quoted Offered quotes 111.23% - 111.23% (111.23%) Residential mortgage-backed securities 614 Broker-quoted Offered quotes 89.80% - 100.99% (100.73%) Foreign governments 16 Broker-quoted Offered quotes 98.38% - 99.01% (98.58%) Equity securities (Salus preferred equity) 4 Income-Approach Yield 7.15% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 14 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables, at fair value 4 Matrix pricing Calculated prices 100.00% Total $ 2,466 Liabilities Future policy benefits $ 725 Discounted cash flow Non-Performance risk spread 0.00% - 0.22% (0.18%) Risk margin to reflect uncertainty 0.35% - 0.71% (0.68%) Derivatives: FIA embedded derivatives included in contractholder funds 2,476 Discounted cash flow Market value of option 0.00% - 31.06% (0.94%) SWAP rates 2.57% - 2.71% (2.63%) Mortality multiplier 80.00% - 80.00% (80.00%) Surrender rates 0.50% - 75.00% (5.90%) Partial withdrawals 1.00% - 2.50% (2.00%) Non-performance spread 0.25% - 0.25% (0.25%) Option cost 0.11% - 16.61% (2.18%) Preferred shares reimbursement feature embedded derivative 29 Black Derman Toy model Credit Spread 5.14% Yield Volatility 20.00% Total liabilities at fair value $ 3,230 Changes in unrealized losses (gains), net in the Company’s FIA embedded derivatives are included in "Benefits and other changes in policy reserves" in the unaudited Condensed Consolidated Statements of Operations. The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three months ended March 31, 2019 and 2018 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended March 31, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 5 $ 114 $ — $ (31 ) $ (24 ) $ 508 Commercial mortgage-backed securities 67 — 2 — — (1 ) — 68 Corporates 1,231 (1 ) 24 — (21 ) (35 ) 11 1,209 Hybrids 10 — — — — — — 10 Municipals 37 — 1 — — — — 38 Residential mortgage-backed securities 614 — 16 7 — (18 ) — 619 Foreign Governments 16 — — — — — — 16 Equity securities 4 — 1 — — — 15 20 Other invested assets: Available-for-sale embedded derivative 14 2 — — — — — 16 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables at fair value 4 — — 5 — — (2 ) 7 Total assets at Level 3 fair value $ 2,466 $ 1 $ 49 $ 126 $ (21 ) $ (85 ) $ — $ 2,536 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,476 $ 244 $ — $ — $ — $ — $ — $ 2,720 Future policy benefits 725 29 — — — 43 — 797 Preferred shares reimbursement feature embedded derivative 29 (2 ) — — — — — 27 Total liabilities at Level 3 fair value $ 3,230 $ 271 $ — $ — $ — $ 43 $ — $ 3,544 (a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2. Three months ended March 31, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 412 $ — $ (2 ) $ 28 $ — $ (6 ) $ (131 ) $ 301 Commercial mortgage-backed securities 49 — (1 ) — — (6 ) — 42 Corporates 1,169 — (20 ) 100 — (34 ) — 1,215 Hybrids 10 — — — — — — 10 Municipals 38 — (1 ) — — — — 37 Residential mortgage-backed securities 66 — — — — (1 ) — 65 Foreign Governments 17 — — — — — — 17 Equity securities 3 1 — — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Funds withheld for reinsurance receivables, at fair value 4 — — 2 — — — 6 Total assets at Level 3 fair value $ 1,785 $ 1 $ (24 ) $ 130 $ — $ (47 ) $ (131 ) $ 1,714 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,277 $ (98 ) $ — $ — $ — $ — $ — $ 2,179 Future policy benefits 728 (20 ) — — — 4 — 712 Preferred shares reimbursements feature embedded derivative 23 1 — — — — — 24 Total liabilities at Level 3 fair value $ 3,028 $ (117 ) $ — $ — $ — $ 4 $ — $ 2,915 (a) The net transfers out of Level 3 during the three months ended March 31, 2018 were exclusively to Level 2. Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments. Mortgage Loans The fair value of mortgage loans is established using a discounted cash flow method based on credit rating, maturity and future income. This yield-based approach is sourced from our third-party vendor. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. In the event of an impairment, the carrying value is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price, or the fair value of the collateral if the loan is collateral-dependent. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy. Policy Loans (included within Other Invested Assets) Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk. Loans with similar characteristics are aggregated for purposes of the calculations. Investment Contracts Investment contracts include deferred annuities, FIAs, indexed universal life policies ("IULs") and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. At March 31, 2019 and December 31, 2018 , this resulted in lower fair value reserves relative to the carrying value. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value. Debt The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy. Our revolving credit facility debt is classified as Level 3 within the fair value hierarchy, and the estimated fair value reflects the carrying value as the revolver has no maturity date. The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described. March 31, 2019 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 56 $ — $ 56 $ 56 Commercial mortgage loans — — 485 485 479 Residential mortgage loans — — 199 199 195 Policy loans, included in other invested assets — — 12 12 23 Affiliated other invested assets — — 40 40 40 Funds withheld for reinsurance receivables, at fair value — — 5 5 5 Total $ — $ 56 $ 741 $ 797 $ 798 Liabilities Investment contracts, included in contractholder funds — — 18,355 18,355 21,161 Debt — 543 — 543 541 Total $ — $ 543 $ 18,355 $ 18,898 $ 21,702 December 31, 2018 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 52 $ — $ 52 $ 52 Commercial mortgage loans — — 483 483 482 Residential mortgage loans — — 187 187 185 Policy loans, included in other invested assets — — 11 11 22 Affiliated other invested assets — — 39 39 39 Funds withheld for reinsurance receivables, at fair value — — 8 8 8 Total $ — $ 52 $ 728 $ 780 $ 788 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 18,358 $ 18,358 $ 20,911 Debt — 520 — 520 541 Total $ — $ 520 $ 18,358 $ 18,878 $ 21,452 The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2018 Form 10-K. Carrying Value After Measurement March 31, 2019 December 31, 2018 Equity securities $ 53 $ 50 Limited partnership investment, included in other invested assets 595 510 For investments for which NAV is used as a practical expedient for fair value, the Company does not have any significant restrictions in their ability to liquidate their positions in these investments, other than obtaining general partner approval, nor does the Company believe it is probable a price less than NAV would be received in the event of a liquidation. The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value. The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the three months ended March 31, 2019 and 2018 , are as follows: Transfers Between Fair Value Levels Level 1 Level 2 Level 3 In Out In Out In Out Three months ended March 31, 2019 Asset-backed securities $ — $ — $ 24 $ — $ — $ 24 Corporates — — — 11 11 — Equity securities 5 17 2 5 15 — Funds withheld for reinsurance receivables — — 2 — — 2 Total transfers $ 5 $ 17 $ 28 $ 16 $ 26 $ 26 Three months ended March 31, 2018 Asset-backed securities $ — $ — $ 131 $ — $ — $ 131 Hybrids 15 — — 15 — — Total transfers $ 15 $ — $ 131 $ 15 $ — $ 131

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangibles A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows: VOBA DAC DSI Total Balance at December 31, 2018 $ 866 $ 344 $ 149 $ 1,359 Deferrals — 91 35 126 Amortization (31 ) (3 ) (2 ) (36 ) Interest 4 2 1 7 Unlocking — — — — Adjustment for net unrealized investment (gains) losses (35 ) — — (35 ) Balance at March 31, 2019 $ 804 $ 434 $ 183 $ 1,421 VOBA DAC DSI Total Balance at December 31, 2017 $ 821 $ 22 $ 10 $ 853 Deferrals — 59 26 85 Amortization (30 ) (1 ) (1 ) (32 ) Interest 5 — — 5 Unlocking — — — — Adjustment for net unrealized investment (gains) losses 38 4 1 43 Balance at March 31, 2018 $ 834 $ 84 $ 36 $ 954 Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01% . The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of March 31, 2019 and 2018 , the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $40 and $22 , respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $5 and $0 , respectively, and the DSI balance included net unrealized investment (gains) losses of $2 and $2 , respectively. Estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year 2019 48 2020 83 2021 89 2022 84 2023 75 Thereafter 385 The Company had an unearned revenue liability balance of $(39) as of March 31, 2019 , including deferrals of $(9) , amortization of $2 , unlocking of $0 , and adjustment for net unrealized investment gains (losses) of $9 . Definite and Indefinite Lived Intangible Assets Amortizable intangible assets as of March 31, 2019 consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) Trade marks / trade names $ 16 $ 2 $ 14 10 State insurance licenses 6 N/A 6 Indefinite Total $ 20

Debt

Debt	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Debt	Debt The carrying amount of the Company's outstanding debt as of March 31, 2019 and December 31, 2018 is as follows: March 31, 2019 December 31, 2018 Debt $ 541 $ 541 As of March 31, 2019 and December 31, 2018 , the company had not drawn on the revolver, which would have carried interest rates equal to 5.25% and 5.27% , respectively, had we drawn on the revolver. As of March 31, 2019 and December 31, 2018 , the amount available to be drawn on the revolver was $ 250 . The interest expense and amortization of debt issuance costs for the three months ended March 31, 2019 and 2018 , respectively, were as follows: Three months ended March 31, 2019 March 31, 2018 Interest Expense Amortization Interest Expense Amortization Debt 8 — 5 — Revolving credit facility — — 1 —

Equity

Equity	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
Equity	Equity Share Repurchases On December 19, 2018, the Company's Board of Directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020 , and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company. During the three months ended March 31, 2019 , the Company repurchased 3,728 thousand shares for a total cost of $30 . As of March 31, 2019 , the Company had repurchased a total of 4,328 thousand shares for a total cost of $34 . Dividends The Company declared the following cash dividend to its common shareholders during the three months ended March 31, 2019 . Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid February 27, 2019 April 1, 2019 March 18, 2019 221,661 $0.01 $2 On May 7, 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on June 10, 2019 to shareholders of record as of the close of business on May 28, 2019. The Company did not declare a cash dividend to its common shareholders during the three months ended March 31, 2018 . The Company declared the following dividends to its preferred shareholders during the three months ended March 31, 2019 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 298 Paid in kind $— 6 Series B Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 108 Paid in kind $— 2 The Company declared the following dividends to its preferred shareholders during the three months ended March 31, 2018 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 29, 2018 April 1, 2018 March 15, 2018 277 Paid in kind $— 5 Series B Preferred Shares March 29, 2018 April 1, 2018 March 15, 2018 101 Paid in kind $— 1

Stock Compensation

Stock Compensation	3 Months Ended
	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Compensation	Stock Compensation On August 8, 2017, the Company adopted a stock-based incentive plan (the “FGL Incentive Plan”) that permits the granting of awards in the form of qualified stock options, non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, unrestricted stock, performance-based awards, dividend equivalents, cash awards and any combination of the foregoing. The Company’s Compensation Committee is authorized to grant up to 15,006 thousand equity awards under the Incentive Plan. At March 31, 2019 , 5,588 thousand equity awards are available for future issuance. FGL Incentive Plan On February 26, 2019 FGL granted 1,699 thousand stock options to a certain officer of the Company. The following table summarizes the vesting conditions for these options: Vesting mechanism Vest Dates Number of options subject to these vesting conditions Service Each March 15 from 2020 through 2023; subject to continued service 485 Service and return on equity performance March 15 2020, 2021 and 2022 subject to continued service and targeted return on equity 607 Service and stock price performance Each March 15 from 2019 through 2023; subject to continued service and target stock price goals being achieved 607 The total fair value of the options granted on February 26, 2019 was $3 . The fair value of the awards is expensed over the service period, which generally corresponds to the vesting period. At March 31, 2019 , the intrinsic value of stock options outstanding or expected to vest was $76 . At March 31, 2019 , the weighted average remaining contractual term of stock options outstanding, exercisable and vested or expected to vest was 7 years , 6 years and 7 years, respectively. At March 31, 2019 there were 485 options that were exercisable. A summary of the Company’s outstanding stock options as of March 31, 2019 , and related activity during the three months ended March 31, 2019 , is as follows (share amount in thousands): Stock Option Awards Options Weighted Average Exercise Price Stock options outstanding at December 31, 2018 13,007 $ 9.68 Granted 1,699 10.00 Exercised — — Forfeited or expired (1,869 ) (10.00 ) Stock options outstanding at March 31, 2019 12,837 9.67 Exercisable at March 31, 2019 485 10.00 Vested or projected to vest at March 31, 2019 12,837 9.67 To value the options granted with service and return on equity performance vesting conditions, we used a Black Scholes valuation model. To value the options granted with stock price market performance vesting conditions, we used a Monte Carlo simulation. The following inputs and assumptions were used in the determination of the grant date fair values of the February 26, 2019 grants for each. Black-Scholes Model Monte Carlo Model Serviced based ROE Performance based Stock Price Performance based Source of input/ assumption Weighted average fair value per options granted $1.68 $1.74 $1.26 N/A Risk-free interest rate 2.48% 2.50% 2.54% US Treasury Curve Assumed dividend yield 0.49% 0.49% 0.49% Internal projection Expected option term 5.75 years 6.0 years N/A Internal model Contractual term N/A N/A 7.0 years N/A Volatility 26.00% 26.00% 26.00% Predecessor and peer group experience Early exercise multiple N/A N/A 2.8 Hull White model Cost of equity N/A N/A 10.50% Capital asset pricing model - 20 year risk free rate The Company granted 147 thousand restricted shares to directors in the three months ended March 31, 2019 . These shares will vest on December 31, 2019. The total fair value of the restricted shares granted in the three months ended March 31, 2019 was $1 . A summary of the Company’s nonvested restricted shares outstanding as of March 31, 2019 , and related activity during the three months ended , is as follows (share amount in thousands): Restricted Stock Awards Shares Weighted Average Grant Date Fair Value Restricted shares outstanding at December 31, 2018 — $ — Granted 147 6.82 Vested — — Forfeited or expired — — Vested or expected to vest at March 31, 2019 147 6.82 Management Incentive Plan In the three months ended March 31, 2019 , the Company granted 424 thousand phantom units to members of management under a management incentive plan (the "Management Incentive Plan"). The total fair value of the restricted shares granted in the three months ended March 31, 2019 was $4 . One half of the phantom units vest in three equal installments on each March 15 th from 2020 to 2022, subject to awardees continued service with the Company. The other half will begin vesting on March 15, 2021 and cliff vest on March 15, 2022 based on continued service and attainment of a performance metric: adjusted operating income return on equity. At March 31, 2019 , the liability for phantom units of $1 was based on the number of units granted, the elapsed portion of the service period and the fair value of the Company’s common stock on that date which was $7.87 . A summary of the Management Incentive Plan nonvested phantom units outstanding as of March 31, 2019 , and related activity during the three months ended , is as follows (share amount in thousands): Phantom units Shares Weighted Average Grant Date Fair Value Phantom units outstanding at December 31, 2018 356 $ 8.95 Granted 424 8.64 Vested (59 ) 10.00 Forfeited or expired (10 ) 8.96 Phantom units outstanding at March 31, 2019 711 9.19 The Company recognized total stock compensation expense related to the FGL Incentive Plan and Management Incentive Plan is as follows: Three months ended March 31, 2019 FGL Incentive Plan Stock options $ 1 Restricted shares — 1 Management Incentive Plan Phantom units — — Total stock compensation expense 1 Related tax benefit — Net stock compensation expense $ 1 The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the unaudited Condensed Consolidated Statements of Operations. Total compensation expense related to the FGL Incentive Plan and Management Incentive Plan not yet recognized as of March 31, 2019 and the weighted-average period over which this expense will be recognized are as follows: Unrecognized Compensation Weighted Average Recognition FGL Incentive Plan Stock options $ 18 3 Restricted shares 1 1 19 Management Incentive Plan Phantom units 3 3 3 Total unrecognized stock compensation expense $ 22 3

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company is a Cayman-domiciled corporation that has operations in Bermuda and the U.S. Neither the Cayman Islands nor Bermuda impose a corporate income tax. The Company’s U.S. non-life subsidiaries file a consolidated non-life U.S. Federal income tax return. The Company’s US life insurance subsidiaries file a separate life consolidated U.S. Federal income tax return. The life insurance companies will be eligible to join in a consolidated filing with the U.S. non-life companies in 2022. The provision for income taxes represents federal income taxes. The effective tax rate for the three months ended March 31, 2019 was 5% . The effective tax rate for the three months ended March 31, 2018 was 38% . The effective tax rate on pre-tax income for the current three months ended March 31, 2019 differs from the U.S Federal statutory rate for 2019 of 21% primarily due to two factors. First, in 2018, a partial valuation allowance was established against the US Life companies' unrealized loss deferred tax assets because there were not sufficient sources of income to recover those assets. During the first quarter of 2019, the unrealized loss position recovered enough that the valuation allowance was no longer needed and it was released. Secondly, the Company had substantial income in jurisdictions that do not impose an income tax. The effective tax rate on pre-tax income for the three months ended March 31, 2018 differed from the U.S. Federal statutory rate for 2018 of 21% primarily due to the impact of an intended tax election. During the first quarter of 2018, there was uncertainty surrounding the impact of the Base-Erosion and Anti-Abuse Tax ("BEAT") that was enacted as part of the Tax Cut and Jobs Act and how it would impact the reinsurance agreement between F&G Life Re and FGL Insurance. As a result of the uncertainty, F&G Life Re intended to make an election under IRC Code Section 953(d) for the 2018 tax year to be treated as if it were a US taxpayer for the year. As such, an opening balance sheet deferred tax liability was set up resulting in a discrete expense being recorded in the first quarter of 2018 that increased the first quarter effective rate. Based on clarifying guidance, the Company ultimately decided not to make that election in the fourth quarter of 2018. As of March 31, 2019 , the Company had a partial valuation allowance of $33 against its gross deferred tax assets of $316 . The valuation allowance is an offset to the non-life companies deferred tax assets and FSRC deferred tax assets. The non-life insurance company subsidiaries have a history of losses and insufficient sources of future income that would allow for recognition of any of their deferred tax assets. FSRC is in a cumulative loss position and does not have a sufficient track record of earnings to recognize any portion of its deferred tax assets The valuation allowance is reviewed quarterly and will be maintained until there is sufficient positive evidence to support a release. At each reporting date, management considers new evidence, both positive and negative, that could impact the future realization of deferred tax assets. Management will consider a release of the valuation allowance once there is sufficient positive evidence that it is more likely than not that the deferred tax assets will be realized. Any release of the valuation allowance will be recorded as a tax benefit increasing net income or other comprehensive income. All other deferred tax assets are more likely than not to be realized based on expectations as to our future taxable income and considering all other available evidence, both positive and negative.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Commitments The Company has unfunded investment commitments as of March 31, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below: March 31, 2019 Asset Type Other invested assets $ 1,093 Equity securities 21 Fixed maturity securities, available-for-sale 39 Other assets 5 Total $ 1,158 As of March 31, 2019 , the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information. Lease Commitments The Company leases office space under non-cancelable operating leases that expire in May 2021. Rent expense and minimum rental commitments under non-cancelable leases are immaterial. Contingencies Regulatory and Litigation Matters The Company is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of the Company's management and in light of existing insurance and other potential indemnification, reinsurance and established accruals, such litigation is not expected to have a material adverse effect on the Company's financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period. The Company is assessed amounts by state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At March 31, 2019 , the Company has accrued $ 2 for guaranty fund assessments that is expected to be offset by estimated future premium tax deductions of $ 2 . The Company has received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. We have established procedures to periodically compare our in-force life insurance and annuity policies against the Death Master File or similar databases; investigate any identified potential matches to confirm the death of the insured; and determine whether benefits are due and attempt to locate the beneficiaries of any benefits due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We believe we have established sufficient reserves with respect to these matters; however, it is possible that third parties could dispute these amounts and additional payments or additional unreported claims or liabilities could be identified which could be significant and could have a material adverse effect on our results of operations. On June 30, 2017, a putative class action complaint was filed against FGL Insurance, FGL, and FS Holdco II Ltd in the United States District Court for the District of Maryland, captioned Brokerage Insurance Partners v. Fidelity & Guaranty Life Insurance Company, Fidelity & Guaranty Life, FS Holdco II Ltd, and John Doe, No. 17-cv-1815. The complaint alleges that FGL Insurance breached the terms of its agency agreement with Brokerage Insurance Partners (“BIP”) and other agents by changing certain compensation terms. The complaint asserts, among other causes of action, breach of contract, defamation, tortious interference with contract, negligent misrepresentation, and violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”). The complaint seeks to certify a class composed of all persons who entered into an agreement with FGL Insurance to sell life insurance and who sold at least one life insurance policy between January 1, 2015 and January 1, 2017. The complaint seeks unspecified compensatory, consequential, and punitive damages in an amount not presently determinable, among other forms of relief. On September 1, 2017, FGL Insurance filed a counterclaim against BIP and John and Jane Does 1-10, asserting, among other causes of action, breach of contract, fraud, civil conspiracy and violations of RICO. On September 22, 2017, Plaintiff filed an Amended Complaint, and on October 16, 2017, FGL Insurance filed an Amended Counterclaim against BIP, Agent Does 1-10, and Other Person Does 1-10. The parties also filed cross-Motions to Dismiss in Part. On August 17, 2018, the Court in the BIP Litigation denied all pending Motions to Dismiss filed by all parties without prejudice, pending a decision as to whether the BIP Litigation will be consolidated into related litigation, captioned Fidelity & Guaranty Life Insurance Company v. Network Partners, et al., Case No. 17-cv-1508. On August 31, 2018, FGL Insurance filed its Answer to BIP’s Amended Complaint. Also on that date, FGL Insurance filed its Answer to Amended Complaint, Affirmative Defenses, and Counterclaim, Filed Pursuant to Fed. R. Civ. P. 12(a)(4)(A). As of March 31, 2019 , BIP has not filed any paper or pleading in response to the Court’s August 17, 2018 Order or to FGL Insurance’s filing. BIP's response date has been adjourned to May 15, 2019. As of the date of this report, the Company does not have sufficient information to determine whether it has exposure to any losses that would be either probable or reasonably estimable.

Reinsurance

Reinsurance	3 Months Ended
	Mar. 31, 2019
Reinsurance Disclosures [Abstract]
Reinsurance	Reinsurance The Company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured. The Company primarily seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies. The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the three months ended March 31, 2019 and 2018 were as follows: Three months ended March 31, 2019 March 31, 2018 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct 57 372 60 41 Assumed — 20 — (21 ) Ceded (41 ) (53 ) (42 ) (59 ) Net 16 339 18 (39 ) Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. The Company did not write off any significant reinsurance balances during the three months ended March 31, 2019 and 2018 . The Company did not commute any ceded reinsurance treaties during the three months ended March 31, 2019 or 2018 . No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues. Effective January 1, 2017, FGL Insurance entered into an indemnity reinsurance agreement with Hannover Re, a third party reinsurer, to reinsure an inforce block of its FIA and fixed deferred annuity contracts with GMWB and Guaranteed Minimum Death Benefit (“GMDB”) guarantees. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of the net retention of guarantee payments in excess of account value for GMWB and GMDB guarantees. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective July 1, 2017, FGL Insurance extended this agreement to include new business issued during 2017. Effective January 1, 2018 FGL Insurance extended this agreement to include new business issued during 2018, and extended the recapture period from 8 to 12 years. Effective January 1, 2019, FGL Insurance extended this agreement to include new business issued during 2019. FGL Insurance incurred risk charge fees of $4 during the three months ended March 31, 2019 , in relation to this reinsurance agreement. Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $758 of certain MYGA and deferred annuity GAAP reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a 40% , 45% , and 63% quota share percentage of these annuity plans for issue years 2013, 2001 through 2012, and 2000 and prior, respectively. Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $4 billion of certain FIA statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes an 80% and 90% quota share percentage of these annuity plans for issue years 2013 through 2014, and 2007 and prior, respectively. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. F&G Reinsurance Companies FSRC, an affiliate of FGL Insurance, has entered into various reinsurance agreements on a funds withheld basis, meaning that funds are withheld by the ceding company from the coinsurance premium owed to FSRC as collateral for FSRC's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC manages the assets supporting the reserves assumed in accordance with the internal investment policy of the ceding companies and applicable law. At March 31, 2019 , FSRC had $286 of funds withheld receivables and $270 of insurance reserves related to these reinsurance treaties. F&G Re, an affiliate of FGL Insurance, has entered into two reinsurance agreements on a funds withheld basis with unaffiliated parties. At March 31, 2019 , F&G Re had $551 of funds withheld receivables and $527 of insurance reserves related to these reinsurance treaties. See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts in "Note 2. Significant Accounting Policies and Practices" within the Company's 2018 Form 10-K.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Affiliated Investments The Company, and certain subsidiaries of the Company, entered into investment management agreements with Blackstone ISG-I Advisors LLC ("BISGA"), a wholly-owned subsidiary of The Blackstone Group LP ("Blackstone") on December 1, 2017. Pursuant to the terms of the investment management agreements, BISGA may delegate certain of its investment management services to sub-managers and any fees or other remuneration payable to such sub-managers is payable by the Company out of the assets managed by such sub-managers. BISGA has delegated certain investment management services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors II”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. As of March 31, 2019 and December 31, 2018 , the Company has a net liability of $25 and $20 , respectively, for the services consumed under the investment management agreements and related sub-management agreements, partially offset by fees received and expense reimbursements from BISGA. During the three months ended March 31, 2019 , the Company received expense reimbursements from BISGA for the services consumed under these agreements. Fees received for these types of services are $2 for the three months ended March 31, 2019 . The Company holds certain fixed income security interests, limited partnerships and bank loans issued by portfolio companies that are affiliates of Blackstone Tactical Opportunities, an affiliate of Blackstone Tactical Opportunities LR Associates-B (Cayman) Ltd (the “Blackstone Fixed Income Securities”) both on a direct and indirect basis. Indirect investments include an investment made in an affiliates’ asset backed fund while direct investments are an investment in affiliates' equity or debt securities. As of March 31, 2019 and December 31, 2018 , the Company held $1,549 and $1,461 in affiliated investments, respectively, which includes foreign exchange unrealized loss of $ (4) and $ (2) , respectively. As of March 31, 2019 and December 31, 2018 , the Company had unfunded commitments relating to affiliated investments of $971 and $990 , respectively. The Company purchased $12 and $185 of residential loans from Finance of America Holdings LLC, a Blackstone affiliate, during the three months ended March 31, 2019 and on December 17, 2018, respectively. On December 1, 2017, the Company executed an agreement with Blackstone Tactical Opportunities Advisors LLC ("BTO Advisors") and Fidelity National Financial, Inc. ("FNF"), to provide the Company transactional and operational services and advice through December 31, 2018. The agreement was amended on November 2, 2018 to provide services through June 30, 2019. The Company will pay fees to BTO Advisors (or its designee(s)), and to FNF in consideration for such services in cash, ordinary shares or warrants exercisable for ordinary shares of the Company. As of March 31, 2019 , no such services have been provided. The Company paid-in-kind dividends on preferred shares held by GSO Capital Partners, an indirect wholly owned subsidiary of The Blackstone Group LP, of 6 thousand shares for the three months ended March 31, 2019 . The Company had no gross realized gains or realized impairment losses on related party investments during the three months ended March 31, 2019 and 2018 .

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2019
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands): Three months ended March 31, 2019 March 31, 2018 Net income (loss) $ 171 $ 65 Less Preferred stock dividend 8 7 Net income (loss) available to common shares 163 58 Weighted-average common shares outstanding - basic 219,646 214,370 Dilutive effect of unvested restricted stock 36 — Weighted-average shares outstanding - diluted 219,682 214,370 Net income (loss) per common share: Basic $ 0.74 $ 0.27 Diluted $ 0.74 $ 0.27 The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL Holdings shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury. The calculation of diluted earnings per share for the three months ended March 31, 2019 excludes the incremental effect of 6 million weighted average common stock warrants outstanding due to their anti-dilutive effect. This calculation also excludes the potential dilutive effect of the 406 thousand preferred stock shares outstanding as of March 31, 2019 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met. The calculation of diluted earnings per share for the three months ended March 31, 2019 excludes the incremental effect related to certain outstanding stock options due to their anti-dilutive effect. The number of weighted average equivalent shares excluded is 1,737 thousand shares for the three months ended March 31, 2019 . The calculation of diluted earnings per share for the three months ended March 31, 2018 excludes the potential dilutive effective of the 377 thousand preferred stock shares outstanding as of March 31, 2018 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met.

Insurance Subsidiary Financial

Insurance Subsidiary Financial Information and Regulatory Matters	3 Months Ended
	Mar. 31, 2019
Insurance [Abstract]
Insurance Subsidiary Financial Information and Regulatory Matters	Insurance Subsidiary Financial Information and Regulatory Matters The Company’s U.S. insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect DAC, DSI and VOBA, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. FSRC (Cayman), F&G Re (Bermuda), and F&G Life Re (Bermuda) file financial statements with their respective regulators that are based on U.S. GAAP. FGL Insurance applies Iowa-prescribed accounting practices that permit Iowa-domiciled insurers to report equity call options used to economically hedge FIA index credits at amortized cost for statutory accounting purposes and to calculate FIA statutory reserves such that index credit returns will be included in the reserve only after crediting to the annuity contract. This resulted in a $ 48 decrease and $30 increase to statutory capital and surplus at March 31, 2019 and December 31, 2018 , respectively. FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $ 100 and $110 at March 31, 2019 and December 31, 2018 , respectively. Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $ 1 and $0 at March 31, 2019 and December 31, 2018 , respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and (deficit) surplus would be $ (4) and $(16) as of March 31, 2019 and December 31, 2018 , respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent. FGL Insurance’s statutory carrying value of Raven Re at March 31, 2019 and December 31, 2018 was $ 97 and $94 , respectively. As of March 31, 2019 , FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices. The prescribed and permitted statutory accounting practices have no impact on the Company’s unaudited condensed consolidated financial statements which are prepared in accordance with GAAP.

Significant Accounting Polici_2

Significant Accounting Policies and Practices (Policies)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all other entities in which the Company has a controlling financial interest and any variable interest entities ("VIEs") in which we are the primary beneficiary. All intercompany accounts and transactions have been eliminated in consolidation.
VIE	We are involved in certain entities that are considered VIEs as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control, to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our unaudited condensed consolidated financial statements . The Company has determined that we are not the primary beneficiary of a VIE as of March 31, 2019 . See "Note 4. Investments" to the Company’s unaudited condensed consolidated financial statements for additional information on the Company’s investments in unconsolidated VIEs.
Significant Accounting Policies and Practices	Adoption of New Accounting Pronouncements Premium Amortization on Purchased Callable Debt Securities In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities) , effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date (as under current GAAP). The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update should be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Amendments to Lease Accounting In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842) ), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update will: • require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less • create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance • not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02 • provide additional guidance on separating the lease components from the nonlease components of a contract • require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases • include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements The amendments are required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company has adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Future Accounting Pronouncements Accounting pronouncements that will impact the Company in future periods have been disclosed in the Company’s 2018 Form 10-K. There have not been any additional accounting pronouncements issued during the quarter ended March 31, 2019 that are expected to impact the Company. The following two pronouncements were discussed in our 2018 Form 10-K but have been included below so as to provide an update on the Company’s status of adoption. New Credit Loss Standard In June 2016, the FASB issued new guidance (ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments) , effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Notable amendments in this update will change the accounting for impairment of most financial assets and certain other instruments in the following ways: • financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset at purchase • credit losses relating to AFS fixed maturity securities will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value • the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount • disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due The amendments in this ASU may be early adopted during any interim or annual period beginning after December 15, 2018, however the Company has elected not to. The Company has identified the material asset classes impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply with the new guidance. The Company has developed a project plan to complete our adoption of this new standard, and is evaluating the impact of the new guidance on its consolidated financial statements. Long-Duration Contracts In August 2018, the FASB issued new guidance (ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts) , effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update: • assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations • the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income • market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income • deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts • deferred acquisition costs must be written off for unexpected contract terminations • disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]
Investments Classified by Contractual Maturity Date [Table Text Block]	The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations. March 31, 2019 Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 160 $ 160 Due after one year through five years 758 749 Due after five years through ten years 2,080 2,059 Due after ten years 10,281 9,994 Subtotal 13,279 12,962 Other securities which provide for periodic payments: Asset-backed securities 5,033 4,974 Commercial mortgage-backed securities 2,596 2,647 Residential mortgage-backed securities 1,000 1,022 Subtotal 8,629 8,643 Total fixed maturity available-for-sale securities $ 21,908 $ 21,605
Consolidated Investments	The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at March 31, 2019 and December 31, 2018 are summarized as follows: March 31, 2019 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for sale securities Asset-backed securities $ 5,033 $ 23 $ (82 ) $ 4,974 $ 4,974 Commercial mortgage-backed securities 2,596 60 (9 ) 2,647 2,647 Corporates 10,886 60 (356 ) 10,590 10,590 Hybrids 988 6 (33 ) 961 961 Municipals 1,211 16 (10 ) 1,217 1,217 Residential mortgage-backed securities 1,000 27 (5 ) 1,022 1,022 U.S. Government 56 — — 56 56 Foreign Governments 138 2 (2 ) 138 138 Total available-for-sale securities 21,908 194 (497 ) 21,605 21,605 Equity securities 1,226 3 (58 ) 1,171 1,171 Derivative investments 318 74 (87 ) 305 305 Commercial mortgage loans 479 — — 485 479 Residential mortgage loans 195 — — 199 195 Other invested assets 759 — (4 ) 744 755 Total investments $ 24,885 $ 271 $ (646 ) $ 24,509 $ 24,510 December 31, 2018 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for sale securities Asset-backed securities $ 4,954 $ 15 $ (137 ) $ 4,832 $ 4,832 Commercial mortgage-backed securities 2,568 9 (40 ) 2,537 2,537 Corporates 11,213 16 (848 ) 10,381 10,381 Hybrids 992 — (91 ) 901 901 Municipals 1,216 3 (32 ) 1,187 1,187 Residential mortgage-backed securities 1,027 12 (8 ) 1,031 1,031 U.S. Government 120 — (1 ) 119 119 Foreign Governments 129 — (8 ) 121 121 Total available-for-sale securities 22,219 55 (1,165 ) 21,109 21,109 Equity securities 1,526 1 (145 ) 1,382 1,382 Derivative investments 330 2 (235 ) 97 97 Commercial mortgage loans 482 — — 483 482 Residential mortgage loans 185 — — 187 185 Other invested assets 662 — — 651 662 Total investments $ 25,404 $ 58 $ (1,545 ) $ 23,909 $ 23,917
Fair Value and Gross Unrealized Losses of Available-for-Sale-Securities	The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows: March 31, 2019 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 2,696 $ (63 ) $ 886 $ (19 ) $ 3,582 $ (82 ) Commercial mortgage-backed securities 243 (4 ) 250 (5 ) 493 (9 ) Corporates 684 (15 ) 7,227 (341 ) 7,911 (356 ) Hybrids 333 (14 ) 343 (19 ) 676 (33 ) Municipals 45 — 482 (10 ) 527 (10 ) Residential mortgage-backed securities 41 (1 ) 238 (4 ) 279 (5 ) U.S. Government — — 50 — 50 — Foreign Government — — 81 (2 ) 81 (2 ) Total available-for-sale securities $ 4,042 $ (97 ) $ 9,557 $ (400 ) $ 13,599 $ (497 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 468 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 1164 Total number of available-for-sale securities in an unrealized loss position 1,632 December 31, 2018 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 2,924 $ (116 ) $ 643 $ (21 ) $ 3,567 $ (137 ) Commercial mortgage-backed securities 1,466 (34 ) 262 (6 ) 1,728 (40 ) Corporates 8,016 (772 ) 1,465 (76 ) 9,481 (848 ) Hybrids 858 (90 ) 7 (1 ) 865 (91 ) Municipals 850 (27 ) 172 (5 ) 1,022 (32 ) Residential mortgage-backed securities 139 (3 ) 190 (5 ) 329 (8 ) U.S. Government 69 — 50 (1 ) 119 (1 ) Foreign Government 47 (3 ) 68 (5 ) 115 (8 ) Total available-for-sale securities $ 14,369 $ (1,045 ) $ 2,857 $ (120 ) $ 17,226 $ (1,165 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,551 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 556 Total number of available-for-sale securities in an unrealized loss position 2,107
Reconciliation of Other-than-Temporary Impairment on Fixed Maturity	Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows: Three months ended March 31, 2019 March 31, 2018 Corporates (2 ) (2 ) Total $ (2 ) $ (2 ) The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the three months ended March 31, 2019 and 2018 , for which a portion of the OTTI was recognized in AOCI: Three months ended March 31, 2019 March 31, 2018 Beginning balance $ — $ — Increases attributable to credit losses on securities: OTTI was previously recognized — — OTTI was not previously recognized — — Ending balance $ — $ — The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the three months ended March 31, 2019 and 2018 : Three months ended March 31, 2019 March 31, 2018 Credit impairment losses in operations $ (2 ) $ (2 ) Change-of-intent losses in operations — — Amortized cost 1 — Fair value 1 — Non-credit losses in other comprehensive income for investments which experienced OTTI — —
Schedule of Accounts, Notes, Loans and Financing Receivable	The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: March 31, 2019 December 31, 2018 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: Hotel 21 4 % 21 4 % Industrial - General 37 8 % 37 8 % Industrial - Warehouse 20 4 % 20 4 % Multifamily 55 11 % 56 12 % Office 146 31 % 147 30 % Retail 200 42 % 201 42 % Total commercial mortgage loans, gross of valuation allowance $ 479 100 % $ 482 100 % Allowance for loan loss — — Total commercial mortgage loans $ 479 $ 482 U.S. Region: East North Central $ 97 20 % $ 98 20 % East South Central 19 4 % 19 4 % Middle Atlantic 78 16 % 79 17 % Mountain 65 14 % 65 13 % New England 10 2 % 10 2 % Pacific 115 24 % 116 24 % South Atlantic 57 12 % 57 12 % West North Central 13 3 % 13 3 % West South Central 25 5 % 25 5 % Total commercial mortgage loans, gross of valuation allowance $ 479 100 % $ 482 100 % Allowance for loan loss — — Total commercial mortgage loans $ 479 $ 482
Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios	The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at March 31, 2019 and December 31, 2018 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 March 31, 2019 LTV Ratios: Less than 50% $ 299 $ 6 $ 305 64 % $ 309 64 % 50% to 60% 163 — 163 34 % 165 34 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 473 $ 6 $ 479 100 % $ 485 100 % December 31, 2018 LTV Ratios: Less than 50% $ 296 $ 6 $ 302 63 % $ 302 63 % 50% to 60% 169 — 169 35 % 170 35 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 476 $ 6 $ 482 100 % $ 483 100 %

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows: March 31, 2019 December 31, 2018 Assets: Derivative investments: Call options $ 304 $ 97 Futures contracts 1 — Other invested assets: Other derivatives and embedded derivatives 17 14 $ 322 $ 111 Liabilities: Contractholder funds: FIA embedded derivative $ 2,720 $ 2,476 Other liabilities: Preferred shares reimbursement feature embedded derivative 27 29 $ 2,747 $ 2,505
FGL's Exposure to Credit Loss on Call Options Held	Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table: March 31, 2019 Counterparty Credit Rating (Fitch/Moody's/S&P) (a) Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 3,496 $ 70 $ 25 $ 45 Deutsche Bank A-/A3/BBB+ 1,151 14 14 — Morgan Stanley */A1/A+ 1,657 25 24 1 Barclay's Bank A+/A2/A 2,752 79 61 18 Canadian Imperial Bank of Commerce */Aa2/A+ 1,430 41 29 12 Wells Fargo A+/A2/A- 2,034 58 56 2 Goldman Sachs A/A3/BBB+ 1,030 17 16 1 Total $ 13,550 $ 304 $ 225 $ 79 December 31, 2018 Counterparty Credit Rating Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 3,952 $ 25 $ — $ 25 Deutsche Bank A-/A3/BBB+ 1,327 5 6 (1 ) Morgan Stanley */A1/A+ 1,648 9 6 3 Barclay's Bank A+/A2/A 2,205 27 20 7 Canadian Imperial Bank of Commerce */Aa2/A+ 1,716 11 8 3 Wells Fargo A+/A2/A- 1,635 17 16 1 Goldman Sachs A/A3/BBB+ 647 3 3 — Total $ 13,130 $ 97 $ 59 $ 38 (a) An * represents credit ratings that were not available.
Derivative Instruments, Gain (Loss) [Table Text Block]	The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows: Three months ended March 31, 2019 March 31, 2018 Revenues: Net investment gains (losses): Call options $ 154 $ (122 ) Futures contracts 8 (2 ) Foreign currency forward 2 — Other derivatives and embedded derivatives 3 — Reinsurance related embedded derivatives (3 ) (21 ) Total net investment gains (losses) $ 164 $ (145 ) Benefits and other changes in policy reserves: FIA embedded derivatives $ 244 $ (98 ) Acquisition and operating expenses, net of deferrals: Preferred shares reimbursement feature embedded derivative $ 2 $ (1 )

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Assets and Liabilities Carrying at Fair Value on Recurring Basis	The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows: March 31, 2019 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 1,357 $ — $ — $ 1,357 $ 1,357 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,466 508 4,974 4,974 Commercial mortgage-backed securities — 2,579 68 2,647 2,647 Corporates — 9,381 1,209 10,590 10,590 Hybrids 277 674 10 961 961 Municipals — 1,179 38 1,217 1,217 Residential mortgage-backed securities — 403 619 1,022 1,022 U.S. Government 51 5 — 56 56 Foreign Governments — 122 16 138 138 Equity securities 441 657 20 1,118 1,118 Derivative investments 1 304 — 305 305 Other invested assets — — 41 41 41 Funds withheld for reinsurance receivables, at fair value 161 664 7 832 832 Total financial assets at fair value $ 2,288 $ 20,434 $ 2,536 $ 25,258 $ 25,258 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds — — 2,720 2,720 2,720 Preferred shares reimbursement feature embedded derivative — — 27 27 27 Fair value of future policy benefits — — 797 797 797 Total financial liabilities at fair value $ — $ — $ 3,544 $ 3,544 $ 3,544 December 31, 2018 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 571 $ — $ — $ 571 $ 571 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,388 444 4,832 4,832 Commercial mortgage-backed securities — 2,470 67 2,537 2,537 Corporates — 9,150 1,231 10,381 10,381 Hybrids 265 626 10 901 901 Municipals — 1,150 37 1,187 1,187 Residential mortgage-backed securities — 417 614 1,031 1,031 U.S. Government 114 5 — 119 119 Foreign Governments — 105 16 121 121 Equity securities 454 874 4 1,332 1,332 Derivative investments — 97 — 97 97 Other invested assets — — 39 39 39 Funds withheld for reinsurance receivables, at fair value 169 576 4 749 749 Total financial assets at fair value $ 1,573 $ 19,858 $ 2,466 $ 23,897 $ 23,897 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ — $ — $ 2,476 $ 2,476 $ 2,476 Preferred shares reimbursement feature embedded derivative — — 29 29 29 Fair value of future policy benefits — — 725 725 725 Total financial liabilities at fair value $ — $ — $ 3,230 $ 3,230 $ 3,230 The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described. March 31, 2019 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 56 $ — $ 56 $ 56 Commercial mortgage loans — — 485 485 479 Residential mortgage loans — — 199 199 195 Policy loans, included in other invested assets — — 12 12 23 Affiliated other invested assets — — 40 40 40 Funds withheld for reinsurance receivables, at fair value — — 5 5 5 Total $ — $ 56 $ 741 $ 797 $ 798 Liabilities Investment contracts, included in contractholder funds — — 18,355 18,355 21,161 Debt — 543 — 543 541 Total $ — $ 543 $ 18,355 $ 18,898 $ 21,702 December 31, 2018 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 52 $ — $ 52 $ 52 Commercial mortgage loans — — 483 483 482 Residential mortgage loans — — 187 187 185 Policy loans, included in other invested assets — — 11 11 22 Affiliated other invested assets — — 39 39 39 Funds withheld for reinsurance receivables, at fair value — — 8 8 8 Total $ — $ 52 $ 728 $ 780 $ 788 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 18,358 $ 18,358 $ 20,911 Debt — 520 — 520 541 Total $ — $ 520 $ 18,358 $ 18,878 $ 21,452
Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis	Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of March 31, 2019 and December 31, 2018 , are as follows: Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) March 31, 2019 March 31, 2019 Assets Asset-backed securities $ 489 Broker-quoted Offered quotes 97.50% - 105.17% (100.84%) Asset-backed securities 19 Third-Party Valuation Offered quotes 0.00% - 98.30% (28.44%) Commercial mortgage-backed securities 43 Broker-quoted Offered quotes 81.01% - 100.14% (87.90%) Commercial mortgage-backed securities 25 Matrix Pricing Quoted prices 121.01% - 121.01% (121.01%) Corporates 731 Broker-quoted Offered quotes 54.00% - 107.83% (99.49%) Corporates 478 Matrix Pricing Quoted prices 95.94% - 117.55% (101.67%) Hybrids 10 Matrix Pricing Quoted prices 98.84% - 98.84% (98.84%) Municipals 38 Broker-quoted Offered quotes 114.61% - 114.61% (114.61%) Residential mortgage-backed securities 619 Broker-quoted Offered quotes 92.52% - 103.81% (103.34%) Foreign governments 16 Broker-quoted Offered quotes 101.38% - 103.55% (102.06%) Equity securities 16 Broker-quoted Offered quotes 100.00% Equity securities (Salus preferred equity) 4 Income-Approach Yield 7.18% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 16 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables at fair value 6 Matrix pricing Quoted prices 100.00% Funds withheld for reinsurance receivables at fair value 1 Loan recovery value Recovery rate 14.00% Total $ 2,536 Liabilities Future policy benefits $ 797 Discounted cash flow Market value of option 0.88% - 6.95% (1.90%) Mortality multiplier 90.00% - 100.00% (100.00%) Surrender rates 0.65% - 40.00% (4.63%) Partial withdrawals 0.00% - 2.50% (0.93%) Non-performance spread 0.00% - 0.10% (0.03%) Option cost 1.14% - 4.58% (1.72%) Risk margin to reflect uncertainty 0.35% - 0.62% (0.44%) Morbidity risk margin 0.00% - 2.00% (0.17%) Derivatives: FIA embedded derivatives included in contractholder funds 2,720 Discounted cash flow Market value of option 0.00% - 32.37% (2.23%) SWAP rates 2.29% - 2.41% (2.34%) Mortality multiplier 80.00% - 80.00% (80.00%) Surrender rates 0.50% - 75.00% (5.86%) Partial withdrawals 1.00% - 2.50% (2.00%) Non-performance spread 0.25% - 0.25% (0.25%) Option cost 0.18% - 16.61% (2.16%) Preferred shares reimbursement feature embedded derivative 27 Black Derman Toy model Credit Spread 4.50% Yield Volatility 20.00% Total liabilities at fair value $ 3,544 Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2018 December 31, 2018 Assets Asset-backed securities $ 405 Broker-quoted Offered quotes 97.00% - 102.00% (99.77%) Asset-backed securities 24 Matrix Pricing Quoted prices 96.07% - 96.07% (96.07%) Asset-backed securities 15 Third-Party Valuation Offered quotes 0.00% - 99.29% (23.05%) Commercial mortgage-backed securities 43 Broker-quoted Offered quotes 77.12% - 100.08% (85.46%) Commercial mortgage-backed securities 24 Matrix Pricing Quoted prices 117.72% - 117.72% (117.72%) Corporates 577 Broker-quoted Offered quotes 74.63% - 104.62% (97.80%) Corporates 654 Matrix Pricing Quoted prices 91.74% - 113.25% (98.86%) Hybrids 10 Matrix Pricing Quoted prices 96.60% - 96.60% (96.60%) Municipals 37 Broker-quoted Offered quotes 111.23% - 111.23% (111.23%) Residential mortgage-backed securities 614 Broker-quoted Offered quotes 89.80% - 100.99% (100.73%) Foreign governments 16 Broker-quoted Offered quotes 98.38% - 99.01% (98.58%) Equity securities (Salus preferred equity) 4 Income-Approach Yield 7.15% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 14 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables, at fair value 4 Matrix pricing Calculated prices 100.00% Total $ 2,466 Liabilities Future policy benefits $ 725 Discounted cash flow Non-Performance risk spread 0.00% - 0.22% (0.18%) Risk margin to reflect uncertainty 0.35% - 0.71% (0.68%) Derivatives: FIA embedded derivatives included in contractholder funds 2,476 Discounted cash flow Market value of option 0.00% - 31.06% (0.94%) SWAP rates 2.57% - 2.71% (2.63%) Mortality multiplier 80.00% - 80.00% (80.00%) Surrender rates 0.50% - 75.00% (5.90%) Partial withdrawals 1.00% - 2.50% (2.00%) Non-performance spread 0.25% - 0.25% (0.25%) Option cost 0.11% - 16.61% (2.18%) Preferred shares reimbursement feature embedded derivative 29 Black Derman Toy model Credit Spread 5.14% Yield Volatility 20.00% Total liabilities at fair value $ 3,230 Changes in unrealized losses (gains), net in the Company’s FIA embedded derivatives are included in "Benefits and other changes in policy reserves" in the unaudited Condensed Consolidated Statements of Operations.
Changes in Fair Value of Financial Instruments - Assets	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three months ended March 31, 2019 and 2018 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended March 31, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 5 $ 114 $ — $ (31 ) $ (24 ) $ 508 Commercial mortgage-backed securities 67 — 2 — — (1 ) — 68 Corporates 1,231 (1 ) 24 — (21 ) (35 ) 11 1,209 Hybrids 10 — — — — — — 10 Municipals 37 — 1 — — — — 38 Residential mortgage-backed securities 614 — 16 7 — (18 ) — 619 Foreign Governments 16 — — — — — — 16 Equity securities 4 — 1 — — — 15 20 Other invested assets: Available-for-sale embedded derivative 14 2 — — — — — 16 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables at fair value 4 — — 5 — — (2 ) 7 Total assets at Level 3 fair value $ 2,466 $ 1 $ 49 $ 126 $ (21 ) $ (85 ) $ — $ 2,536 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,476 $ 244 $ — $ — $ — $ — $ — $ 2,720 Future policy benefits 725 29 — — — 43 — 797 Preferred shares reimbursement feature embedded derivative 29 (2 ) — — — — — 27 Total liabilities at Level 3 fair value $ 3,230 $ 271 $ — $ — $ — $ 43 $ — $ 3,544 (a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2. Three months ended March 31, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 412 $ — $ (2 ) $ 28 $ — $ (6 ) $ (131 ) $ 301 Commercial mortgage-backed securities 49 — (1 ) — — (6 ) — 42 Corporates 1,169 — (20 ) 100 — (34 ) — 1,215 Hybrids 10 — — — — — — 10 Municipals 38 — (1 ) — — — — 37 Residential mortgage-backed securities 66 — — — — (1 ) — 65 Foreign Governments 17 — — — — — — 17 Equity securities 3 1 — — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Funds withheld for reinsurance receivables, at fair value 4 — — 2 — — — 6 Total assets at Level 3 fair value $ 1,785 $ 1 $ (24 ) $ 130 $ — $ (47 ) $ (131 ) $ 1,714 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,277 $ (98 ) $ — $ — $ — $ — $ — $ 2,179 Future policy benefits 728 (20 ) — — — 4 — 712 Preferred shares reimbursements feature embedded derivative 23 1 — — — — — 24 Total liabilities at Level 3 fair value $ 3,028 $ (117 ) $ — $ — $ — $ 4 $ — $ 2,915 (a) The net transfers out of Level 3 during the three months ended March 31, 2018 were exclusively to Level 2.
Changes in Fair Value of Financial Instruments - Liabilities	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three months ended March 31, 2019 and 2018 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended March 31, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 5 $ 114 $ — $ (31 ) $ (24 ) $ 508 Commercial mortgage-backed securities 67 — 2 — — (1 ) — 68 Corporates 1,231 (1 ) 24 — (21 ) (35 ) 11 1,209 Hybrids 10 — — — — — — 10 Municipals 37 — 1 — — — — 38 Residential mortgage-backed securities 614 — 16 7 — (18 ) — 619 Foreign Governments 16 — — — — — — 16 Equity securities 4 — 1 — — — 15 20 Other invested assets: Available-for-sale embedded derivative 14 2 — — — — — 16 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables at fair value 4 — — 5 — — (2 ) 7 Total assets at Level 3 fair value $ 2,466 $ 1 $ 49 $ 126 $ (21 ) $ (85 ) $ — $ 2,536 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,476 $ 244 $ — $ — $ — $ — $ — $ 2,720 Future policy benefits 725 29 — — — 43 — 797 Preferred shares reimbursement feature embedded derivative 29 (2 ) — — — — — 27 Total liabilities at Level 3 fair value $ 3,230 $ 271 $ — $ — $ — $ 43 $ — $ 3,544 (a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2. Three months ended March 31, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 412 $ — $ (2 ) $ 28 $ — $ (6 ) $ (131 ) $ 301 Commercial mortgage-backed securities 49 — (1 ) — — (6 ) — 42 Corporates 1,169 — (20 ) 100 — (34 ) — 1,215 Hybrids 10 — — — — — — 10 Municipals 38 — (1 ) — — — — 37 Residential mortgage-backed securities 66 — — — — (1 ) — 65 Foreign Governments 17 — — — — — — 17 Equity securities 3 1 — — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Funds withheld for reinsurance receivables, at fair value 4 — — 2 — — — 6 Total assets at Level 3 fair value $ 1,785 $ 1 $ (24 ) $ 130 $ — $ (47 ) $ (131 ) $ 1,714 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,277 $ (98 ) $ — $ — $ — $ — $ — $ 2,179 Future policy benefits 728 (20 ) — — — 4 — 712 Preferred shares reimbursements feature embedded derivative 23 1 — — — — — 24 Total liabilities at Level 3 fair value $ 3,028 $ (117 ) $ — $ — $ — $ 4 $ — $ 2,915 (a) The net transfers out of Level 3 during the three months ended March 31, 2018 were exclusively to Level 2.
Schedule of Net Asset Value	The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2018 Form 10-K. Carrying Value After Measurement March 31, 2019 December 31, 2018 Equity securities $ 53 $ 50 Limited partnership investment, included in other invested assets 595 510
Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class	The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the three months ended March 31, 2019 and 2018 , are as follows: Transfers Between Fair Value Levels Level 1 Level 2 Level 3 In Out In Out In Out Three months ended March 31, 2019 Asset-backed securities $ — $ — $ 24 $ — $ — $ 24 Corporates — — — 11 11 — Equity securities 5 17 2 5 15 — Funds withheld for reinsurance receivables — — 2 — — 2 Total transfers $ 5 $ 17 $ 28 $ 16 $ 26 $ 26 Three months ended March 31, 2018 Asset-backed securities $ — $ — $ 131 $ — $ — $ 131 Hybrids 15 — — 15 — — Total transfers $ 15 $ — $ 131 $ 15 $ — $ 131

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Information Regarding Intangible Assets, VOBA and DAC	A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows: VOBA DAC DSI Total Balance at December 31, 2018 $ 866 $ 344 $ 149 $ 1,359 Deferrals — 91 35 126 Amortization (31 ) (3 ) (2 ) (36 ) Interest 4 2 1 7 Unlocking — — — — Adjustment for net unrealized investment (gains) losses (35 ) — — (35 ) Balance at March 31, 2019 $ 804 $ 434 $ 183 $ 1,421 VOBA DAC DSI Total Balance at December 31, 2017 $ 821 $ 22 $ 10 $ 853 Deferrals — 59 26 85 Amortization (30 ) (1 ) (1 ) (32 ) Interest 5 — — 5 Unlocking — — — — Adjustment for net unrealized investment (gains) losses 38 4 1 43 Balance at March 31, 2018 $ 834 $ 84 $ 36 $ 954 Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01% . The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of March 31, 2019 and 2018 , the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $40 and $22 , respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $5 and $0 , respectively, and the DSI balance included net unrealized investment (gains) losses of $2 and $2 , respectively.
Estimated Amortization Expense for VOBA in Future Fiscal Periods	Estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year 2019 48 2020 83 2021 89 2022 84 2023 75 Thereafter 385

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Schedule of Debt	The interest expense and amortization of debt issuance costs for the three months ended March 31, 2019 and 2018 , respectively, were as follows: Three months ended March 31, 2019 March 31, 2018 Interest Expense Amortization Interest Expense Amortization Debt 8 — 5 — Revolving credit facility — — 1 —

Equity (Tables)

Equity (Tables)	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
Dividends Declared	The Company declared the following cash dividend to its common shareholders during the three months ended March 31, 2019 . Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid February 27, 2019 April 1, 2019 March 18, 2019 221,661 $0.01 $2 On May 7, 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on June 10, 2019 to shareholders of record as of the close of business on May 28, 2019. The Company did not declare a cash dividend to its common shareholders during the three months ended March 31, 2018 . The Company declared the following dividends to its preferred shareholders during the three months ended March 31, 2019 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 298 Paid in kind $— 6 Series B Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 108 Paid in kind $— 2

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Summary of Unfunded Commitments	summary of unfunded commitments by invested asset class are included below: March 31, 2019 Asset Type Other invested assets $ 1,093 Equity securities 21 Fixed maturity securities, available-for-sale 39 Other assets 5 Total $ 1,158 As of March 31, 2019 , the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

Reinsurance (Tables)

Reinsurance (Tables)	3 Months Ended
	Mar. 31, 2019
Reinsurance Disclosures [Abstract]
Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes	The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the three months ended March 31, 2019 and 2018 were as follows: Three months ended March 31, 2019 March 31, 2018 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct 57 372 60 41 Assumed — 20 — (21 ) Ceded (41 ) (53 ) (42 ) (59 ) Net 16 339 18 (39 )

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2019
Earnings Per Share [Abstract]
Summary of Basic and Diluted EPS	The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands): Three months ended March 31, 2019 March 31, 2018 Net income (loss) $ 171 $ 65 Less Preferred stock dividend 8 7 Net income (loss) available to common shares 163 58 Weighted-average common shares outstanding - basic 219,646 214,370 Dilutive effect of unvested restricted stock 36 — Weighted-average shares outstanding - diluted 219,682 214,370 Net income (loss) per common share: Basic $ 0.74 $ 0.27 Diluted $ 0.74 $ 0.27

Basis of Presentation and Nat_2

Basis of Presentation and Nature of Business - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Goodwill	$ 467	$ 467

Significant Accounting Polici_3

Significant Accounting Policies and Practices (Details)	3 Months Ended
	Mar. 31, 2018
Benefits and Other Changes in Policy Reserves [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Immaterial Error Correction	21
Amortization of Intangible Assets [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Immaterial Error Correction	4
income tax expense [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Immaterial Error Correction	4

Significant Risks and Uncerta_2

Significant Risks and Uncertainties - Narrative (Details) $ in Millions	Mar. 31, 2019USD ($)issuer	Dec. 31, 2018USD ($)issuer
Concentration Risk [Line Items]
Exposure of FGL's invested assets	10.00%	7.00%
Fair Value In Investments		$ 1,634
Number of issuers in investment | issuer	0	16
Wilton Reassurance Company
Concentration Risk [Line Items]
Net amount recoverable	$ 1,541
Kubera Reassurance Company [Member]
Concentration Risk [Line Items]
Net amount recoverable	$ 681
Scottish Re [Member]
Concentration Risk [Line Items]
Ceded Credit Risk, Disclosure	47
All Financial Instruments
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 2,348	$ 2,491
Exposure of FGL's invested assets	10.00%	10.00%
Single Issuer
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 124	$ 115
Exposure of FGL's invested assets	1.00%	1.00%
Banking Industry | All Financial Instruments
Concentration Risk [Line Items]
Investment securities held by subsidiaries subject to specialized industry accounting principles, amortized cost	$ 2,416	$ 2,691
Top Ten Holdings [Member]
Concentration Risk [Line Items]
Exposure of FGL's invested assets	35.00%
Number of issuers in investment | issuer	107
Minimum
Concentration Risk [Line Items]
Exposure of FGL's invested assets		10.00%

Investments - Credit Impairment

Investments - Credit Impairment Loss Type (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Schedule of Investments [Line Items]
Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Including Credit Impairments	$ (2)	$ (2)
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Change in Status	0	0
Amortized cost	21,908		$ 22,219
Available-for-sale Securities	21,605		$ 21,109
Other than temporary impairment, non-credit losses recognized in OCI	0	0
Asset Backed Securities and Corporate Securities [Member]
Schedule of Investments [Line Items]
Amortized cost	1	0
Available-for-sale Securities	$ 1	$ 0

Investments - Available-for-Sa

Investments - Available-for-Sale Securities Table (Details) $ in Millions	Mar. 31, 2019USD ($)Security	Dec. 31, 2018USD ($)Security
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	$ 21,908	$ 22,219
Available-for sale securities
Gross Unrealized Gains	194	55
Gross Unrealized Losses	(497)	(1,165)
Fair Value	21,605	21,109
Carrying Value	21,605	21,109
Equity Securities, Amortized Cost Basis	1,226	1,526
Investments, Cost or Amortized Cost	24,885	25,404
Investments, Accumulated Gross Unrealized Gain, before Tax	271	58
Investments, Accumulated Gross Unrealized Loss, before Tax	646	1,545
Investments, Fair Value Disclosure	24,509	23,909
Equity Securities, Accumulated Gross Unrealized Gain, before Tax	3	1
Equity Securities, Accumulated Gross Unrealized Loss, before tax	(58)	(145)
Equity Securities, Fair Value	1,171	1,382
Equity Securities, Carrying Value	1,171	1,382
Derivative investments
Amortized Cost	318	330
Gross Unrealized Gains	74	2
Gross Unrealized Losses	(87)	(235)
Fair Value	305	97
Carrying Value	305	97
Commercial mortgage loans
Loans and Leases Receivable, Net Amount	674	667
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	9,557	2,857
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(400)	(120)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	13,599	17,226
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ (497)	$ (1,165)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	468	1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	1,164	556
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Security	1,632	2,107
Investments	$ 24,510	$ 23,917
Asset-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	5,033	4,954
Available-for sale securities
Gross Unrealized Gains	23	15
Gross Unrealized Losses	(82)	(137)
Fair Value	4,974	4,832
Carrying Value	4,974	4,832
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	886	643
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(19)	(21)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	3,582	3,567
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(82)	(137)
Commercial mortgage-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	2,596	2,568
Available-for sale securities
Gross Unrealized Gains	60	9
Gross Unrealized Losses	(9)	(40)
Fair Value	2,647	2,537
Carrying Value	2,647	2,537
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	250	262
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(5)	(6)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	493	1,728
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(9)	(40)
Corporates
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	10,886	11,213
Available-for sale securities
Gross Unrealized Gains	60	16
Gross Unrealized Losses	(356)	(848)
Fair Value	10,590	10,381
Carrying Value	10,590	10,381
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	7,227	1,465
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(341)	(76)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	7,911	9,481
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(356)	(848)
Hybrids
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	988	992
Available-for sale securities
Gross Unrealized Gains	6	0
Gross Unrealized Losses	(33)	(91)
Fair Value	961	901
Carrying Value	961	901
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	343	7
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(19)	(1)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	676	865
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(33)	(91)
Municipals
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,211	1,216
Available-for sale securities
Gross Unrealized Gains	16	3
Gross Unrealized Losses	(10)	(32)
Fair Value	1,217	1,187
Carrying Value	1,217	1,187
Residential mortgage-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,000	1,027
Available-for sale securities
Gross Unrealized Gains	27	12
Gross Unrealized Losses	(5)	(8)
Fair Value	1,022	1,031
Carrying Value	1,022	1,031
U.S. Government
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	56	120
Available-for sale securities
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(1)
Fair Value	56	119
Carrying Value	56	119
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	50	50
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0	(1)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	50	119
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	0	(1)
Foreign Government Debt Securities [Member]
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	138	129
Available-for sale securities
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	2	0
Gross Unrealized Losses	(2)	(8)
Fair Value	138	121
Carrying Value	138	121
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	81
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(2)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	81
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(2)
Other invested assets
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	759	662
Available-for sale securities
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(4)	0
Fair Value	744	651
Carrying Value	755	662
Municipals
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	482	172
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(10)	(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	527	1,022
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(10)	(32)
Residential mortgage-backed securities
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	238	190
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(4)	(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	279	329
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(5)	(8)
Commercial Portfolio Segment [Member]
Commercial mortgage loans
Investment, Commercial Mortgage Loans, Amortized Cost	479	482
Investments, Commercial Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Investments, Commercial Mortgage Loans, Accumulated Gross Unrealized Loss before Tax	0	0
Investments, Commercial Mortgage Loans, Fair Value Disclosure	485	483
Loans and Leases Receivable, Net Amount	479	482
Residential Portfolio Segment [Member]
Commercial mortgage loans
Loans and Leases Receivable, Net Amount	195	185
Investment, Residential Mortgage Loans, Amortized Cost	195	185
Investments, Residential Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Investments, Residential Mortgage Loans, Fair Value Disclosure	$ 199	187
Predecessor | Foreign Government Debt Securities [Member]
Total investments
Available-for-sale securities, Fair Value, 12 months or longer		68
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value		115
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss		$ (8)

Investments - Amortized Cost a

Investments - Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Schedule of Available-for-sale Securities [Line Items]
Equity Securities, Amortized Cost Basis	$ 1,226	$ 1,526
Due in one year or less, Amortized Cost	160
Due after one year through five years, Amortized Cost	758
Due after five years through ten years, Amortized Cost	2,080
Due after ten years, Amortized Cost	10,281
Subtotal, Amortized Cost	13,279
Other securities which provide for periodic payments, Amortized Cost	8,629
Total fixed maturity available-for-sale securities, Amortized Cost	21,908	$ 22,219
Due in one year or less, Fair Value	160
Due after one year through five years, Fair Value	749
Due after five years through ten years, Fair Value	2,059
Due after ten years, Fair Value	9,994
Subtotal, Fair Value	12,962
Other securities which provide for periodic payments, Fair Value	8,643
Total fixed maturity available-for-sale securities, Fair Value	21,605
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	5,033
Other securities which provide for periodic payments, Fair Value	4,974
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	2,596
Other securities which provide for periodic payments, Fair Value	2,647
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	1,000
Other securities which provide for periodic payments, Fair Value	$ 1,022

Investments - Fair Value and G

Investments - Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details)	Mar. 31, 2019USD ($)Security	Dec. 31, 2018USD ($)Security
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 4,042,000,000	$ 14,369,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(97,000,000)	(1,045,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	9,557,000,000	2,857,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(400,000,000)	(120,000,000)
Available-for-sale securities, Fair Value, Total	13,599,000,000	17,226,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (497,000,000)	$ (1,165,000,000)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	468	1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	1,164	556
Total number of available-for-sale securities in an unrealized loss position | Security	1,632	2,107
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income		$ 0
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 2,696,000,000	2,924,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(63,000,000)	(116,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	886,000,000	643,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(19,000,000)	(21,000,000)
Available-for-sale securities, Fair Value, Total	3,582,000,000	3,567,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(82,000,000)	(137,000,000)
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	243,000,000	1,466,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(4,000,000)	(34,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	250,000,000	262,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(5,000,000)	(6,000,000)
Available-for-sale securities, Fair Value, Total	493,000,000	1,728,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(9,000,000)	(40,000,000)
Corporates
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	684,000,000	8,016,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(15,000,000)	(772,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	7,227,000,000	1,465,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(341,000,000)	(76,000,000)
Available-for-sale securities, Fair Value, Total	7,911,000,000	9,481,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(356,000,000)	(848,000,000)
Hybrids
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	333,000,000	858,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(14,000,000)	(90,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	343,000,000	7,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(19,000,000)	(1,000,000)
Available-for-sale securities, Fair Value, Total	676,000,000	865,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(33,000,000)	(91,000,000)
Municipals
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	45,000,000	850,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	0	(27,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	482,000,000	172,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(10,000,000)	(5,000,000)
Available-for-sale securities, Fair Value, Total	527,000,000	1,022,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(10,000,000)	(32,000,000)
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	41,000,000	139,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1,000,000)	(3,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	238,000,000	190,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(4,000,000)	(5,000,000)
Available-for-sale securities, Fair Value, Total	279,000,000	329,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(5,000,000)	(8,000,000)
U.S. Government
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months		69,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		0
Available-for-sale securities, Fair Value, 12 months or longer	50,000,000	50,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	0	(1,000,000)
Available-for-sale securities, Fair Value, Total	50,000,000	119,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	0	(1,000,000)
Foreign Government Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, 12 months or longer	81,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(2,000,000)
Available-for-sale securities, Fair Value, Total	81,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (2,000,000)
Predecessor | Foreign Government Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months		47,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		(3,000,000)
Available-for-sale securities, Fair Value, 12 months or longer		68,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer		(5,000,000)
Available-for-sale securities, Fair Value, Total		115,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total		$ (8,000,000)

Investments - Reconciliation o

Investments - Reconciliation of Other than Temporary Impairment on Fixed Maturity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Balance at the beginning of the period	$ 0	$ 0
Increases attributable to credit losses on securities:
OTTI was previously recognized	0	0
OTTI was not previously recognized	0	0
Balance at the end of the period	$ 0	$ 0

Investments - Other-than-Tempo

Investments - Other-than-Temporary Impairments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Investments [Line Items]
Document Period End Date	Mar. 31, 2019
Total other-than-temporary impairments	$ (2)	$ (2)
Corporates
Schedule of Investments [Line Items]
Total other-than-temporary impairments	$ (2)	(2)
Predecessor
Schedule of Investments [Line Items]
Total other-than-temporary impairments		$ (2)

Investments - Schedule of Comm

Investments - Schedule of Commercial Mortgage Loan Investment (Details) $ in Millions	Mar. 31, 2019USD ($)loan	Dec. 31, 2018USD ($)loan	Mar. 31, 2019USD ($)
Schedule of Investments [Line Items]
Document Period End Date			Mar. 31, 2019
Impaired loans, number | loan	0	0
Commercial mortgage loans	$ 479	$ 482	$ 479
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Loans and Leases Receivable, Net Amount	$ 674	$ 667	$ 674
Hotel
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 21	$ 21	$ 21
Commercial mortgage loans, % of total	4.00%	4.00%	4.00%
Industrial - General
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 37	$ 37	$ 37
Commercial mortgage loans, % of total	8.00%	8.00%	8.00%
Industrial - Warehouse
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 20	$ 20	$ 20
Commercial mortgage loans, % of total	4.00%	4.00%	4.00%
Multifamily
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 55	$ 56	$ 55
Commercial mortgage loans, % of total	11.00%	12.00%	11.00%
Office
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 146	$ 147	$ 146
Commercial mortgage loans, % of total	31.00%	30.00%	31.00%
Retail
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 200	$ 201	$ 200
Commercial mortgage loans, % of total	42.00%	42.00%	42.00%
LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 305	$ 302	$ 305
Commercial mortgage loans, % of total	64.00%	63.00%	64.00%
LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 163	$ 169	$ 163
Commercial mortgage loans, % of total	34.00%	35.00%	34.00%
LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 11	$ 11	$ 11
Commercial mortgage loans, % of total	2.00%	2.00%	2.00%
East North Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 97	$ 98	$ 97
Commercial mortgage loans, % of total	20.00%	20.00%	20.00%
East South Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 19	$ 19	$ 19
Commercial mortgage loans, % of total	4.00%	4.00%	4.00%
Middle Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 78	$ 79	$ 78
Commercial mortgage loans, % of total	16.00%	17.00%	16.00%
Mountain
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 65	$ 65	$ 65
Commercial mortgage loans, % of total	14.00%	13.00%	14.00%
New England
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 10	$ 10	$ 10
Commercial mortgage loans, % of total	2.00%	2.00%	2.00%
Pacific
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 115	$ 116	$ 115
Commercial mortgage loans, % of total	24.00%	24.00%	24.00%
South Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 57	$ 57	$ 57
Commercial mortgage loans, % of total	12.00%	12.00%	12.00%
West North Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 13	$ 13	$ 13
Commercial mortgage loans, % of total	3.00%	3.00%	3.00%
West South Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 25	$ 25	$ 25
Commercial mortgage loans, % of total	5.00%	5.00%	5.00%
Greater than 1.25
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 473	$ 476	$ 473
Greater than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	299	296	299
Greater than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	163	169	163
Greater than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	11	11	11
Greater than 1.00 but less than 1.25
Schedule of Investments [Line Items]
Commercial mortgage loans	6	6	6
Greater than 1.00 but less than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	6	6	6
Greater than 1.00 but less than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	0	0	0
Greater than 1.00 but less than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	0	0	0
Fair Value
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 485	$ 483	$ 485
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Fair Value | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 309	$ 302	$ 309
Commercial mortgage loans, % of total	64.00%	63.00%	64.00%
Fair Value | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 165	$ 170	$ 165
Commercial mortgage loans, % of total	34.00%	35.00%	34.00%
Fair Value | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 11	$ 11	$ 11
Commercial mortgage loans, % of total	2.00%	2.00%	2.00%
Commercial Portfolio Segment [Member]
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 479	$ 482	$ 479
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Allowance for loan loss	$ 0	$ 0	$ 0
Loans and Leases Receivable, Net Amount	$ 479	$ 482	$ 479

Investments - Net Investment I

Investments - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Investments [Line Items]
Document Period End Date	Mar. 31, 2019
Gross investment income	$ 317
Investment expense	(28)
Net investment income	289
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	265
Equity securities
Schedule of Investments [Line Items]
Gross investment income	21
Commercial mortgage loans
Schedule of Investments [Line Items]
Gross investment income	7
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	3
Other investments
Schedule of Investments [Line Items]
Gross investment income	5
Funds Withheld [Member]
Schedule of Investments [Line Items]
Gross investment income	8	$ 7
Limited Partnership [Member]
Schedule of Investments [Line Items]
Gross investment income	$ 8	3
Predecessor
Schedule of Investments [Line Items]
Gross investment income		273
Investment expense		(10)
Net investment income		263
Predecessor | Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income		242
Predecessor | Equity securities
Schedule of Investments [Line Items]
Gross investment income		10
Predecessor | Commercial mortgage loans
Schedule of Investments [Line Items]
Gross investment income		7
Predecessor | Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income		3
Predecessor | Other investments
Schedule of Investments [Line Items]
Gross investment income		$ 1

Investments - Net Investment G

Investments - Net Investment Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Gain (Loss) on Investments [Line Items]
Document Period End Date	Mar. 31, 2019
Net realized losses on fixed maturity available-for-sale securities	$ (3)	$ (37)
Realized gains on equity securities	78	(6)
Change in fair value of other derivatives and embedded derivatives	3	0
Realized losses on other invested assets	1	(3)
Realized gains (losses) on certain derivative instruments	(26)	11
Unrealized gains (losses) on certain derivative instruments	190	(135)
Derivative, Gain (Loss) on Derivative, Net	(3)	(21)
Change In Fair Value Derivatives, Including Other Derivatives	164	(145)
Realized gains (losses) on hedging derivatives and reinsurance-related embedded derivatives	164	(145)
Net investment gains (losses)	$ 240	(191)
Predecessor
Gain (Loss) on Investments [Line Items]
Net investment gains (losses)		$ (191)

Investments - Narrative (Detai

Investments - Narrative (Details)	Mar. 31, 2019USD ($)loan	Dec. 31, 2018USD ($)loan	Mar. 31, 2019USD ($)	Mar. 31, 2018USD ($)	Jun. 30, 2015USD ($)
Schedule of Available-for-sale Securities [Line Items]
Non-income producing investment fair value	$ 0	$ 0	$ 0
FHLB collateral pledged	1,186,000,000	1,401,000,000	1,186,000,000
Available for sale depressed securities fair value disclosure	40,000,000	132,000,000	$ 40,000,000
Percentage of available for sale depressed securities above amortized cost			20.00%
Other than temporary impairment credit losses recognized in earnings, including credit impairments			$ 2,000,000	$ 2,000,000
Other than temporary impairment credit losses recognized in earnings, reductions, change in status			0	0
Amortized cost	21,908,000,000	22,219,000,000	21,908,000,000
Fair Value	$ 21,605,000,000	$ 21,109,000,000	21,605,000,000
Other than temporary impairment, non-credit losses recognized in OCI			0	0
Realized gains (losses) on other invested assets			1,000,000	(3,000,000)
Impaired loans, number | loan	0	0
Unrealized Gain (Loss) on Investments			724,000,000	(359,000,000)
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Unrealized Gain Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income	$ 0	$ 0	0
Unrealized losses related to non-credit portion of OTTI included in AOCI		0
Asset Backed Securities and Corporate Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	1,000,000		1,000,000	0
Fair Value	1,000,000		1,000,000	0
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	1,000,000,000	1,027,000,000	1,000,000,000
Fair Value	1,022,000,000	1,031,000,000	1,022,000,000
Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Assets held by insurance regulators	$ 16,135,000,000	$ 19,930,000,000	16,135,000,000
Proceeds from available-for-sale investments, sold, matured or repaid:			$ 962,000,000	3,286,000,000
Commercial mortgage loans
Schedule of Available-for-sale Securities [Line Items]
Investments, costs or amortized, percentage of total investments	2.00%		2.00%
Loan to value, threshold	75.00%	75.00%	75.00%
Total fixed maturities | Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:			$ 474,000,000
Gain on sale of investments			5,000,000
Loss on sale of investments			(10,000,000)
Predecessor | Total fixed maturities | Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:				2,778,000,000
Gain on sale of investments				8,000,000
Loss on sale of investments				$ (43,000,000)
Commitment to Invest
Schedule of Available-for-sale Securities [Line Items]
Unfunded investment commitment	$ 1,158,000,000		1,158,000,000
Crescent Capital BDC Inc. | Commitment to Invest
Schedule of Available-for-sale Securities [Line Items]
Unfunded investment commitment					$ 75,000,000
Other Investments	54,000,000		54,000,000
Golub Capital Partners 10, L.P. [Member] | Commitment to Invest
Schedule of Available-for-sale Securities [Line Items]
Unfunded investment commitment	595,000,000		595,000,000
Other Investments	$ 1,093,000,000		$ 1,093,000,000

Investments Impact of Adoption

Investments Impact of Adoption of New Accounting Pronouncement (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net investment gains (losses)	$ 240	$ (191)
Gain (Loss) on Sale of Equity Investments	78	(6)
Unrealized Gain (Loss) on Investments	$ 724	$ (359)

Investments Schedule of Residen

Investments Schedule of Residential Mortgage Loan Investment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Document Period End Date	Mar. 31, 2019
Commercial mortgage loans	$ 479,000,000	$ 482,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Residential Mortgage [Member]
Investments, costs or amortized, percentage of total investments	1.00%
FLORIDA
Commercial mortgage loans	$ 29,000,000	$ 25,000,000
Residential Mortgage Receivable, Percentage of Total	15.00%	14.00%
ILLINOIS
Commercial mortgage loans	$ 25,000,000	$ 24,000,000
Residential Mortgage Receivable, Percentage of Total	13.00%	13.00%
NEW JERSEY
Commercial mortgage loans	$ 24,000,000	$ 17,000,000
Residential Mortgage Receivable, Percentage of Total	13.00%
All Other States [Member]
Commercial mortgage loans	$ 112,000,000	$ 114,000,000
Residential Mortgage Receivable, Percentage of Total	59.00%	64.00%
Residential Portfolio Segment [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 195,000,000	$ 185,000,000
Commercial mortgage loans	$ 190,000,000	$ 180,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Loans and Leases Receivable, Allowance	$ 0	$ 0
Performing [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 195,000,000	$ 185,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Non-performing [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 0	$ 0
Residential Mortgage Receivable, Percentage of Total	0.00%	0.00%
Maximum | All Other States [Member]
Residential Mortgage Receivable, Percentage of Total	9.00%	9.00%

Derivative Financial Instrume_3

Derivative Financial Instruments - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Total asset derivatives	$ 322	$ 111
Total liability derivatives	2,747	2,505
Call options | Derivative Instruments
Derivative [Line Items]
Total asset derivatives	304	97
Futures contracts | Derivative Instruments
Derivative [Line Items]
Total asset derivatives	1	0
Other derivatives and embedded derivatives | Other invested assets
Derivative [Line Items]
Total asset derivatives	17	14
FIA embedded derivative | Contractholder funds
Derivative [Line Items]
Total liability derivatives	2,720	2,476
Preferred shares reimbursement feature embedded derivative | Other Liabilities [Member]
Derivative [Line Items]
Total liability derivatives	$ 27	$ 29

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Change in Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	$ (3)	$ (21)
Change In Fair Value Of Derivatives	164	(145)
Call options | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	154	(122)
Futures contracts | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	8	(2)
Foreign Exchange Forward [Member] | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	2	0
Other derivatives and embedded derivatives | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	3	0
Reinsurance related embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	(3)	(21)
Preferred shares reimbursement feature embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	2	(1)
FIA embedded derivative
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	$ 244	$ (98)

Derivative Financial Instrume_5

Derivative Financial Instruments - FGL's Exposure to Credit Loss on Call Options Held (Detail) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Fair Value	$ 322	$ 111
Merrill Lynch
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/*/A+
Deutsche Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A-/A3/BBB+
Notional Amount	$ 1,151	1,327
Fair Value	14	5
Collateral	14	6
Net Credit Risk	$ 0	(1)
Morgan Stanley
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/A1/A+
Notional Amount	$ 1,657	1,648
Fair Value	25	9
Collateral	24	6
Net Credit Risk	$ 1	3
Barclay's Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/A2/A
Notional Amount	$ 2,752	2,205
Fair Value	79	27
Collateral	61	20
Net Credit Risk	$ 18	7
Canadian Imperial Bank of Commerce [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/Aa2/A+
Notional Amount	$ 1,430	1,716
Fair Value	41	11
Collateral	29	8
Net Credit Risk	$ 12	3
Wells Fargo [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/A2/A-
Notional Amount	$ 2,034	1,635
Fair Value	58	17
Collateral	56	16
Net Credit Risk	$ 2	1
GOLDMAN SACH MTF [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A/A3/BBB+
Notional Amount	$ 1,030	647
Fair Value	17	3
Collateral	16	3
Net Credit Risk	1	0
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivatives, Fair Value [Line Items]
Notional Amount	13,550	13,130
Fair Value	304	97
Collateral	225	59
Net Credit Risk	79	38
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Merrill Lynch
Derivatives, Fair Value [Line Items]
Notional Amount	3,496	3,952
Fair Value	70	25
Collateral	25	0
Net Credit Risk	$ 45	$ 25

Derivative Financial Instrume_6

Derivative Financial Instruments - Narrative (Details) $ in Millions	Nov. 30, 2017shares	Mar. 31, 2019USD ($)contract	Mar. 31, 2018USD ($)	Dec. 31, 2018USD ($)contract	Dec. 31, 2017USD ($)	Jun. 16, 2014USD ($)
Derivative [Line Items]
Fair Value		$ 322		$ 111
Fair value of assets		2,536		$ 2,466
Derivative, Gain (Loss) on Derivative, Net		$ (3)	$ (21)
Other derivatives and embedded derivatives
Derivative [Line Items]
Term of contract, term one		1 year
Term of contract, term two		2 years
Term of contract, term three		3 years
Term of contract, term four		5 years
Futures contracts
Derivative [Line Items]
Number of instruments held | contract		774,000,000		664,000,000
Collateral held		$ 4		$ 3
Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Fair Value		17		14
Derivative investments | Call options
Derivative [Line Items]
Fair Value		304		97
Derivative investments | Futures contracts
Derivative [Line Items]
Fair Value		1		0
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		304		97
Derivative notional amount		13,550		13,130
Collateral posted		225		59
Maximum amount of loss due to credit risk		79		38
Cash and Cash Equivalents | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Collateral posted		200		59
Other Investments Asset | Other invested assets
Derivative [Line Items]
Fixed maturities securities, available-for-sale, at fair value		27		26		$ 35
Other Investments Asset | Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Derivative notional amount						$ 11
Merrill Lynch [Member] | Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		70		25
Derivative notional amount		3,496		3,952
Collateral posted		25		0
Maximum amount of loss due to credit risk		45		$ 25
Predecessor
Derivative [Line Items]
Fair value of assets			1,714		$ 1,785
Preferred Stock
Derivative [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Preferred stock dividend rate	10.00%
Series A Cumulative Preferred Stock [Member] | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	275,000
Series B Cumulative Preferred Stock [Member] | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	100,000
Net investment (losses) gains | Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		2	0
Net investment (losses) gains | Other derivatives and embedded derivatives
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		3	0
Net investment (losses) gains | Call options
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		154	(122)
Net investment (losses) gains | Futures contracts
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		$ 8	$ (2)

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Assets and Liabilities Carrying at Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	$ 271
Available-for-sale Securities	21,605			$ 21,109
Derivative investments	305			97
Total financial assets at fair value	2,536			2,466
Funds withheld for reinsurance receivables, at fair value	837			757
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	1
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	0			0
Cash and cash equivalents	1,357
Equity securities	441
Derivative investments	1
Total financial assets at fair value	2,288
FHLB common stock	0			0
Commercial mortgage loans	0			0
Investments, Affiliated Bank Loan, Fair Value Disclosure	0			0
Funds withheld for reinsurance receivables, at fair value	0			0
Total assets carried on balance sheet at amounts other than fair value	0			0
Liabilities Related to Investment Contracts, Fair Value Disclosure	0			0
Total liabilities carried on balance sheet at amounts other than fair value	0			0
Debt Instrument, Fair Value Disclosure	0			0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	56			52
Cash and cash equivalents	0
Equity securities	657
Derivative investments	304
Total financial assets at fair value	20,434
FHLB common stock	0			0
Commercial mortgage loans	0			0
Investments, Affiliated Bank Loan, Fair Value Disclosure	0			0
Funds withheld for reinsurance receivables, at fair value	0			0
Total assets carried on balance sheet at amounts other than fair value	56			52
Liabilities Related to Investment Contracts, Fair Value Disclosure	0			0
Total liabilities carried on balance sheet at amounts other than fair value	543			520
Debt Instrument, Fair Value Disclosure	543			520
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	0			0
Cash and cash equivalents	0
Equity securities	20
Derivative investments	0
Total financial assets at fair value	2,536
FHLB common stock	485			483
Commercial mortgage loans	12			187
Investments, Affiliated Bank Loan, Fair Value Disclosure	40			39
Funds withheld for reinsurance receivables, at fair value	5			8
Total assets carried on balance sheet at amounts other than fair value	741			728
Liabilities Related to Investment Contracts, Fair Value Disclosure	18,355			18,358
Total liabilities carried on balance sheet at amounts other than fair value	18,355			18,358
Debt Instrument, Fair Value Disclosure	0			0
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	56			52
Cash and cash equivalents	1,357
Equity securities	1,118
Derivative investments	305
Total financial assets at fair value	25,258
FHLB common stock	485			483
Commercial mortgage loans	12			187
Investments, Affiliated Bank Loan, Fair Value Disclosure	40			39
Funds withheld for reinsurance receivables, at fair value	5			8
Total assets carried on balance sheet at amounts other than fair value	797			780
Liabilities Related to Investment Contracts, Fair Value Disclosure	18,355			18,358
Total liabilities carried on balance sheet at amounts other than fair value	18,898			18,878
Debt Instrument, Fair Value Disclosure	543			520
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	56			52
Cash and cash equivalents	1,357
Equity securities	1,118
Derivative investments	305
Total financial assets at fair value	25,258
FHLB common stock	479			482
Commercial mortgage loans	23			185
Investments, Affiliated Bank Loan, Fair Value Disclosure	40			39
Funds withheld for reinsurance receivables, at fair value	5			8
Total assets carried on balance sheet at amounts other than fair value	798			788
Liabilities Related to Investment Contracts, Fair Value Disclosure	21,161			20,911
Total liabilities carried on balance sheet at amounts other than fair value	21,702			21,452
Debt Instrument, Fair Value Disclosure	541			541
Fixed indexed annuities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Fixed indexed annuities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Fixed indexed annuities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,544
Fixed indexed annuities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,544
Fixed indexed annuities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,544
Future Contracts [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Future Contracts [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Future Contracts [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,720
Future Contracts [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,720
Future Contracts [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,720
Future Policy Benefits [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Future Policy Benefits [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Future Policy Benefits [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	797
Future Policy Benefits [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	797
Future Policy Benefits [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	797
Preferred shares reimbursement feature embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Preferred shares reimbursement feature embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Preferred shares reimbursement feature embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	27
Preferred shares reimbursement feature embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	(2)	$ 1
Available-for-sale Securities	27	24		29	$ 23
Preferred shares reimbursement feature embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	27
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,974			4,832
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,466
Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	508
Asset-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,974
Asset-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,974
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,647			2,537
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,579
Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	68
Commercial mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,647
Commercial mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,647
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,590			10,381
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	(1)
Corporates | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Corporates | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	9,381
Corporates | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,209
Corporates | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,590
Corporates | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,590
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	961			901
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Hybrids | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	277
Hybrids | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	674
Hybrids | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10
Hybrids | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	961
Hybrids | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	961
Municipals
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Municipals | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Municipals | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,179
Municipals | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	38
Municipals | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,217
Municipals | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,217
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,022			1,031
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	403
Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	619
Residential mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,022
Residential mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,022
U.S. Government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	56			119
U.S. Government | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	51
U.S. Government | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	5
U.S. Government | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
U.S. Government | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	56
U.S. Government | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	56
Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	138			121
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Foreign Government Debt Securities [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Foreign Government Debt Securities [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	122
Foreign Government Debt Securities [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	16
Foreign Government Debt Securities [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	138
Foreign Government Debt Securities [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	138
Other invested assets | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	41
Other invested assets | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	41
Other invested assets | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	41
Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0	0
Reinsurance Receivables, Funds Withheld [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	161			169
Reinsurance Receivables, Funds Withheld [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	664			576
Reinsurance Receivables, Funds Withheld [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	7			4
Reinsurance Receivables, Funds Withheld [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	832			749
Reinsurance Receivables, Funds Withheld [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 832			749
Predecessor
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings		(117)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		1
Predecessor | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				571
Equity securities				454
Derivative investments				0
Other invested assets				0
Total financial assets at fair value				1,573
Commercial mortgage loans				0
Financial Liabilities Fair Value Disclosure				0
Predecessor | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				0
Equity securities				874
Derivative investments				97
Other invested assets				0
Total financial assets at fair value				19,858
Commercial mortgage loans				0
Financial Liabilities Fair Value Disclosure				0
Predecessor | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				0
Equity securities				4
Derivative investments				0
Other invested assets				39
Total financial assets at fair value				2,466
Commercial mortgage loans				11
Financial Liabilities Fair Value Disclosure				3,230
Predecessor | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				571
Equity securities				1,332
Derivative investments				97
Other invested assets				39
Total financial assets at fair value				23,897
Commercial mortgage loans				11
Financial Liabilities Fair Value Disclosure				3,230
Predecessor | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				571
Equity securities				1,332
Derivative investments				97
Other invested assets				39
Total financial assets at fair value				23,897
Commercial mortgage loans				22
Financial Liabilities Fair Value Disclosure				3,230
Predecessor | Fixed indexed annuities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				0
Predecessor | Fixed indexed annuities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				0
Predecessor | Fixed indexed annuities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				2,476
Predecessor | Fixed indexed annuities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				2,476
Predecessor | Fixed indexed annuities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				2,476
Predecessor | Call options | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Call options | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Call options | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				725
Predecessor | Call options | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				725
Predecessor | Call options | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				725
Predecessor | Preferred shares reimbursement feature embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Preferred shares reimbursement feature embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Preferred shares reimbursement feature embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				29
Predecessor | Preferred shares reimbursement feature embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				29
Predecessor | Preferred shares reimbursement feature embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				29
Predecessor | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				4,388
Predecessor | Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				444
Predecessor | Asset-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				4,832
Predecessor | Asset-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				4,832
Predecessor | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				2,470
Predecessor | Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				67
Predecessor | Commercial mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				2,537
Predecessor | Commercial mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				2,537
Predecessor | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Corporates | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Corporates | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				9,150
Predecessor | Corporates | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,231
Predecessor | Corporates | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				10,381
Predecessor | Corporates | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				10,381
Predecessor | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Hybrids | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				265
Predecessor | Hybrids | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				626
Predecessor | Hybrids | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				10
Predecessor | Hybrids | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				901
Predecessor | Hybrids | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				901
Predecessor | Municipals
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Municipals | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Municipals | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,150
Predecessor | Municipals | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				37
Predecessor | Municipals | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,187
Predecessor | Municipals | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,187
Predecessor | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		$ 0
Predecessor | Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				417
Predecessor | Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				614
Predecessor | Residential mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,031
Predecessor | Residential mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,031
Predecessor | U.S. Government | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				114
Predecessor | U.S. Government | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				5
Predecessor | U.S. Government | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | U.S. Government | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				119
Predecessor | U.S. Government | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				119
Predecessor | Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings			$ 0
Predecessor | Foreign Government Debt Securities [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Foreign Government Debt Securities [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				105
Predecessor | Foreign Government Debt Securities [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				16
Predecessor | Foreign Government Debt Securities [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				121
Predecessor | Foreign Government Debt Securities [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				$ 121

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 2,536,000,000	$ 2,466,000,000
Future Policy Benefit		725,000,000
Liabilities, fair value	3,544,000,000	$ 3,230,000,000
Risk Margin To Reflect Uncertainty		0.00%
Credit Spread	$ 0.0450	$ 0.0514
Yield Volatility	0.00%	0.00%
Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 489,000,000	$ 405,000,000
Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	43,000,000	43,000,000
Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	731,000,000	577,000,000
Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	38,000,000	37,000,000
Market Approach | Foreign Government Debt Securities [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 16,000,000	16,000,000
Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Loan Recovery Value		$ 25,000,000
Fair value inputs, quoted prices	100.00%	100.00%
Fair Value Input Recovery Rate		7.15%
Market Approach | Residential mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 619,000,000
Residential Mortage Backed securities		$ 614,000,000
Market Approach | Credit Linked Note [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	25,000,000
Third Parties [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	19,000,000	15,000,000
Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		654,000,000
Income Approach Valuation Technique | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 10,000,000
Income Approach Valuation Technique | Equity securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 16,000,000
Fair Value Input Recovery Rate	100.00%
Income Approach Valuation Technique | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	100.00%	100.00%
Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.03%	0.18%
Black Scholes Model [Member] | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 16,000,000
Matrix Pricing Valuation [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 24,000,000
Matrix Pricing Valuation [Member] | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	25,000,000	$ 24,000,000
Matrix Pricing Valuation [Member] | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	478,000,000
Matrix Pricing Valuation [Member] | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 10,000,000
Matrix Pricing Valuation [Member] | Funds withheld for reinsurance liabilities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	100.00%	100.00%
Loan Recovery Valuation [Member] | Funds withheld for reinsurance liabilities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	14.00%
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Liabilities, fair value	$ 2,720,000,000	$ 2,476,000,000
Preferred shares reimbursement feature embedded derivative | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Liabilities, fair value	$ 27,000,000	$ 29,000,000
Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Minimum | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	97.50%	97.00%
Minimum | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	54.00%	74.63%
Minimum | Market Approach | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.84%	96.60%
Minimum | Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	114.61%	111.23%
Minimum | Market Approach | Foreign Government Debt Securities [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.38%	98.38%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	92.52%	89.80%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	121.01%	117.72%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	95.94%	91.74%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.00%	0.00%
Minimum | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Minimum | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	90.00%
Minimum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%	0.00%
Fair value inputs, swap rates	2.29%	2.57%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	0.50%	0.05%
Fair value inputs, non performance spread	0.25%	0.03%
Minimum | Fixed indexed annuities | Partial Withdrawls [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, surrender rates	1.00%	1.00%
Minimum | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, non performance spread	0.18%	0.01%
Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Maximum | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	105.17%	102.00%
Maximum | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	107.83%	104.62%
Maximum | Market Approach | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.84%	96.60%
Maximum | Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	114.61%	111.23%
Maximum | Market Approach | Foreign Government Debt Securities [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.55%	99.01%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.81%	100.99%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	121.01%	117.72%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	117.55%	113.25%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.10%	0.22%
Maximum | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.30%	99.29%
Maximum | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	100.00%
Maximum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	32.37%	31.06%
Fair value inputs, swap rates	2.41%	2.71%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	75.00%	75.00%
Fair value inputs, non performance spread	0.25%	0.03%
Maximum | Fixed indexed annuities | Partial Withdrawls [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.50%	2.50%
Maximum | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, non performance spread	16.61%	16.61%
Weighted Average | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.84%	99.77%
Weighted Average | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	99.49%	97.80%
Weighted Average | Market Approach | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.84%	96.60%
Weighted Average | Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	114.61%	111.23%
Weighted Average | Market Approach | Foreign Government Debt Securities [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	102.06%	98.58%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.34%	100.73%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	121.01%	117.72%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.67%	98.86%
Weighted Average | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	28.44%	23.05%
Weighted Average | Third Party Valuation Technique [Member] | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	87.90%	85.46%
Weighted Average | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	100.00%
Weighted Average | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	2.23%	94.00%
Fair value inputs, swap rates	2.34%	2.63%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	2.86%	5.90%
Fair value inputs, non performance spread	0.25%	0.03%
Weighted Average | Fixed indexed annuities | Partial Withdrawls [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.00%	2.00%
Weighted Average | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, non performance spread	2.16%	2.18%
Insurance Subsidiary | Market Approach | Equity securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 4,000,000
Insurance Subsidiary | Income Approach Valuation Technique | Equity securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 4,000,000
Fair Value Input Recovery Rate	7.18%
Insurance Subsidiary | Income Approach Valuation Technique | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 14,000,000
Insurance Subsidiary | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value Inputs, Other Loan Recoveries	81.01%	77.12%
Insurance Subsidiary | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value Inputs, Other Loan Recoveries	100.14%	100.08%
Loan Participation - JSN Jewelry, Inc. [Member] | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Reinsurance Receivables, Funds Withheld		$ 4,000,000

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Changes to Fair Value of Financial Instruments Level 3 (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	$ 21,605			$ 21,109
Assets, Fair Value Disclosure	2,536			2,466
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,466
Assets, Total Gains (Losses) Included in Earnings	1
Assets, Total Gains (Losses) Included in AOCI	49
Assets, Purchases	126
Assets, Sales	21
Assets, Settlements	85
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	2,536
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	3,230
Liabilities, Total Gains (Losses) Included in Earnings	271
Liabilities, Total Gains (Losses) Included in AOCI	0
Liabilities, Purchases	0
Liabilities, Sales	0
Liabilities, Settlements	43
Liabilities, Net transfer In (Out) of Level 3	0
Balance at End of Period	3,544
Liabilities, fair value	3,544			3,230
FIA embedded derivatives, included in contractholder funds
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,476
Liabilities, Total Gains (Losses) Included in Earnings	244
Liabilities, Total Gains (Losses) Included in AOCI	0
Liabilities, Purchases	0
Liabilities, Sales	0
Liabilities, Settlements	0
Liabilities, Net transfer In (Out) of Level 3	0
Balance at End of Period	2,720
Future Policy Benefits [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	725	$ 728
Liabilities, Total Gains (Losses) Included in Earnings	29	(20)
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	0	0
Liabilities, Sales	0	0
Liabilities, Settlements	43	4
Liabilities, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	797	712
Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	4,974			4,832
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	444
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	5
Assets, Purchases	114
Assets, Sales	0
Assets, Settlements	(31)
Assets, Net transfer In (Out) of Level 3	(24)
Balance at End of Period	508
Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	2,647			2,537
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	67
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	2
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	1
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	68
Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	10,590			10,381
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1,231
Assets, Total Gains (Losses) Included in Earnings	(1)
Assets, Total Gains (Losses) Included in AOCI	24
Assets, Purchases	0
Assets, Sales	(21)
Assets, Settlements	(35)
Assets, Net transfer In (Out) of Level 3	11
Balance at End of Period	1,209
Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	961			901
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	10
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	10
Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	138			121
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	16
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	16
Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	37
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	1
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	38
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	4
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	1
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	15
Balance at End of Period	20
Available-for-sale embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	14
Assets, Total Gains (Losses) Included in Earnings	2
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	16
Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	1,022			1,031
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	614
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	16
Assets, Purchases	7
Assets, Sales	0
Assets, Settlements	18
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	619
Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	4	4
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	5	2
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	(2)	0
Balance at End of Period	7	6
Market Approach | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	489			405
Market Approach | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	43			43
Market Approach | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	731			577
Market Approach | Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	16			16
Market Approach | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	38			37
Market Approach | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	619
Third Parties [Member] | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	19			15
Matrix Pricing Valuation [Member] | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				24
Matrix Pricing Valuation [Member] | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	25			24
Matrix Pricing Valuation [Member] | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	478
Matrix Pricing Valuation [Member] | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	10
Matrix Pricing Valuation [Member] | Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	6
Loan Recovery Valuation [Member] | Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	1
Income Approach Valuation Technique | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				654
Income Approach Valuation Technique | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				10
Income Approach Valuation Technique | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	16
Black Scholes Model [Member] | Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	16
Affiliated Entity | HGI Energy Note [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	25
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	25
Affiliated Entity | Market Approach | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				4
Affiliated Entity | Income Approach Valuation Technique | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	4
Affiliated Entity | Income Approach Valuation Technique | Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				14
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value	2,720			2,476
Preferred shares reimbursement feature embedded derivative | Income Approach Valuation Technique
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value	27			29
Fair Value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	25,258
Fair Value | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	4,974
Fair Value | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	2,647
Fair Value | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	10,590
Fair Value | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	961
Fair Value | Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	138
Fair Value | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	1,217
Fair Value | Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	41
Fair Value | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	1,022
Fair Value | Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	832			749
Fair Value | Fixed indexed annuities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	3,544
Fair Value | Preferred shares reimbursement feature embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	27	24		29	$ 23
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, Total Gains (Losses) Included in Earnings	(2)	1
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	0	0
Liabilities, Sales	0	0
Liabilities, Settlements	0	0
Liabilities, Net transfer In (Out) of Level 3	0	0
Predecessor
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		1,785
Assets, Total Gains (Losses) Included in Earnings		1
Assets, Total Gains (Losses) Included in AOCI		(24)
Assets, Purchases		130
Assets, Sales		0
Assets, Settlements		(47)
Assets, Net transfer In (Out) of Level 3		(131)
Balance at End of Period		1,714
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		3,028
Liabilities, Total Gains (Losses) Included in Earnings		(117)
Liabilities, Total Gains (Losses) Included in AOCI		0
Liabilities, Purchases		0
Liabilities, Sales		0
Liabilities, Settlements		4
Liabilities, Net transfer In (Out) of Level 3		0
Balance at End of Period		2,915
Predecessor | FIA embedded derivatives, included in contractholder funds
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		2,277
Liabilities, Total Gains (Losses) Included in Earnings		(98)
Liabilities, Total Gains (Losses) Included in AOCI		0
Liabilities, Purchases		0
Liabilities, Sales		0
Liabilities, Settlements		0
Liabilities, Net transfer In (Out) of Level 3		0
Balance at End of Period		2,179
Predecessor | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		412
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		(2)
Assets, Purchases		28
Assets, Sales		0
Assets, Settlements		(6)
Assets, Net transfer In (Out) of Level 3		(131)
Balance at End of Period		301
Predecessor | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		49
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		(1)
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		(6)
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		42
Predecessor | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		1,169
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		(20)
Assets, Purchases		100
Assets, Sales		0
Assets, Settlements		(34)
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		1,215
Predecessor | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		10
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		10
Predecessor | Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period			$ 17
Assets, Total Gains (Losses) Included in Earnings			0
Assets, Total Gains (Losses) Included in AOCI			0
Assets, Purchases			0
Assets, Sales			0
Assets, Settlements			0
Assets, Net transfer In (Out) of Level 3			0
Balance at End of Period			$ 17
Predecessor | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		38
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		(1)
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		37
Predecessor | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		3
Assets, Total Gains (Losses) Included in Earnings		1
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		4
Predecessor | Available-for-sale embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		17
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		17
Predecessor | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		66
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		1
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		$ 65
Predecessor | Fair Value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				23,897
Predecessor | Fair Value | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				4,832
Predecessor | Fair Value | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				2,537
Predecessor | Fair Value | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				10,381
Predecessor | Fair Value | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				901
Predecessor | Fair Value | Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				121
Predecessor | Fair Value | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				1,187
Predecessor | Fair Value | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				1,031
Predecessor | Fair Value | Preferred shares reimbursement feature embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				$ 29
FSRC [Member] | Income Approach Valuation Technique | Future Policy Benefits [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value	$ 797

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - NAV (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Private Equity Funds [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying value after measurement	$ 595	$ 510
Equity securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying value after measurement	53	$ 50
Level 1
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	0
Level 2
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	0
Level 3
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	199
Fair Value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	199
Carrying Value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	$ 195

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Narrative (Detail)	Nov. 30, 2017	Mar. 31, 2019USD ($)$ / Contract	Dec. 31, 2018USD ($)	Jun. 30, 2018USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings		$ 271,000,000
Assets, net transfer in (out) of Level 3		0
Risk Margin To Reflect Uncertainty			0.00%
Credit Spread		$ 0.0450	$ 0.0514
Yield Volatility		0.00%	0.00%
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		$ (24,000,000)
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		11,000,000
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		$ 15,000,000
Market Approach | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		100.00%	100.00%
Fair Value Input Recovery Rate			7.15%
Income Approach Valuation Technique | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, strike price | $ / Contract		0
Fair value inputs, black scholes model		100.00%	100.00%
Income Approach Valuation Technique | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Input Recovery Rate		100.00%
Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		0.03%	0.18%
Matrix Pricing Valuation [Member] | Funds withheld for reinsurance liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		100.00%	100.00%
Loan Recovery Valuation [Member] | Funds withheld for reinsurance liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		14.00%
Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Preferred Stock, Dividend Rate, Percentage, Less Than Par	90.00%
Available-for-sale Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held by insurance regulators		$ 16,135,000,000	$ 19,930,000,000
FSRC and F&G Re [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Undiscounted Cash flows used in fair value measurement				$ 1,152,000,000
Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty			0.00%
Maximum | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		105.17%	102.00%
Maximum | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		107.83%	104.62%
Maximum | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		98.84%	96.60%
Maximum | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		114.61%	111.23%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		103.81%	100.99%
Maximum | Market Approach | Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		103.55%	99.01%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			96.07%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		121.01%	117.72%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		117.55%	113.25%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		0.10%	0.22%
Maximum | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		98.30%	99.29%
Weighted Average | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		100.84%	99.77%
Weighted Average | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		99.49%	97.80%
Weighted Average | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		98.84%	96.60%
Weighted Average | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		114.61%	111.23%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		103.34%	100.73%
Weighted Average | Market Approach | Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		102.06%	98.58%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			96.07%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		121.01%	117.72%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		101.67%	98.86%
Weighted Average | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		28.44%	23.05%
Weighted Average | Third Party Valuation Technique [Member] | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		87.90%	85.46%
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty			0.00%
Minimum | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		97.50%	97.00%
Minimum | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		54.00%	74.63%
Minimum | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		98.84%	96.60%
Minimum | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		114.61%	111.23%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		92.52%	89.80%
Minimum | Market Approach | Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		101.38%	98.38%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			96.07%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		121.01%	117.72%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		95.94%	91.74%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		0.00%	0.00%
Minimum | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		0.00%	0.00%
Affiliated Entity | Income Approach Valuation Technique | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Input Recovery Rate		7.18%
Affiliated Entity | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Other Loan Recoveries		100.14%	100.08%
Affiliated Entity | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Other Loan Recoveries		81.01%	77.12%
Future Policy Benefits, Market Value of Option [Member] | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		6.95%
Future Policy Benefits, Market Value of Option [Member] | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		1.90%
Future Policy Benefits, Market Value of Option [Member] | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		0.88%
Future Policy Benefits [Member] | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption		0.02
Fair value inputs, swap rates		40.00%
Fair value inputs, mortality multiplier		2.50%
Fair value inputs, non performance spread		4.58%
Risk Margin To Reflect Uncertainty		0.62%
Future Policy Benefits [Member] | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption		0.0017
Fair value inputs, swap rates		4.63%
Fair value inputs, mortality multiplier		0.93%
Fair value inputs, non performance spread		1.72%
Risk Margin To Reflect Uncertainty		0.44%
Future Policy Benefits [Member] | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption		0
Fair value inputs, swap rates		0.65%
Fair value inputs, mortality multiplier		0.00%
Fair value inputs, non performance spread		1.14%
Risk Margin To Reflect Uncertainty		0.35%
Fixed indexed annuities | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		32.37%	31.06%
Fair value inputs, swap rates		2.41%	2.71%
Fair value inputs, mortality multiplier		80.00%	80.00%
Fair value inputs, surrender rates		75.00%	75.00%
Fair value inputs, non performance spread		0.25%	0.03%
Fixed indexed annuities | Maximum | Partial Withdrawls [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates		2.50%	2.50%
Fixed indexed annuities | Maximum | Option Cost [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread		16.61%	16.61%
Fixed indexed annuities | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		2.23%	94.00%
Fair value inputs, swap rates		2.34%	2.63%
Fair value inputs, mortality multiplier		80.00%	80.00%
Fair value inputs, surrender rates		2.86%	5.90%
Fair value inputs, non performance spread		0.25%	0.03%
Fixed indexed annuities | Weighted Average | Partial Withdrawls [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates		2.00%	2.00%
Fixed indexed annuities | Weighted Average | Option Cost [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread		2.16%	2.18%
Fixed indexed annuities | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		0.00%	0.00%
Fair value inputs, swap rates		2.29%	2.57%
Fair value inputs, mortality multiplier		80.00%	80.00%
Fair value inputs, surrender rates		0.50%	0.05%
Fair value inputs, non performance spread		0.25%	0.03%
Fixed indexed annuities | Minimum | Partial Withdrawls [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates		1.00%	1.00%
Fixed indexed annuities | Minimum | Option Cost [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread		0.18%	0.01%

Fair Value of Financial Instr_8

Fair Value of Financial Instruments - Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	$ 17	$ 0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	28	131
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	16	15
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	26	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	26	131
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	5	15
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	24
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	24
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	0
Asset-backed securities | Predecessor
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount		131
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount		0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount		0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount		131
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount		0
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	0
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	11
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	11
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	0
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount		0
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount		15
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount		0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount		0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount		$ 15
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	17
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	2
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	5
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	15
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	5
Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	2
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	2
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	$ 0

Intangible Assets - Schedule of

Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount	$ 1,421	$ 1,359
FGL [Member] | Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net	$ 14
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
FGL [Member] | Licensing Agreements [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount	$ 6

Intangible Assets - Summary of

Intangible Assets - Summary of Changes in Carrying Amounts of Intangible Assets Including DAC, VOBA , and DSI (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Deferred Sales Inducement Cost, Net	$ 183	$ 36	$ 149	$ 10
VOBA
VOBA at beginning of period	866	821
Deferrals	0	0
Amortization	(31)	(30)
Interest	4	5
Unlocking	0	0
Adjustment for net unrealized investment (gains) losses	(35)	38
VOBA at end of period	804	834
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	0	1
Deferred Sales Inducement Cost, Unlocking Adjustment	0	0
Deferred Sales Inducement Cost, Amortization Expense, Accrued Interest	1	0
Deferred Sales Inducement Cost, Amortization Expense	(2)	(1)
Deferred Sales Inducement Cost, Addition	35	26
DAC
DAC at beginning of period	434	84	344	22
Deferrals	91	59
Amortization	(3)	(1)
Interest	2	0
Unlocking	0	0
Adjustment for net unrealized investment (gains) losses	0	4
DAC at end of period	434	84	344	22
Total
Total VOBA and DAC at beginning of period	1,421	954	$ 1,359	$ 853
Deferrals	126	85
Amortization	(36)	(32)
Unlocking	0	0
Adjustment for net unrealized investment (gains) losses	(35)	43
Interest	$ 7	$ 5

Intangible Assets - Definite Li

Intangible Assets - Definite Lived Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Intangibles, net	$ 1,421	$ 1,359
FGL [Member] | Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	16
Finite-Lived Intangible Assets, Accumulated Amortization	2
Finite-Lived Intangible Assets, Net	$ 14
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
FGL [Member] | Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net	$ 6
Licensing Agreements [Member] | FGL [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, net	$ 6

Intangible Assets - Narrative (

Intangible Assets - Narrative (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Unearned Revenue, Net	$ (39)
Unearned Revenue, Unlocking Adjustment	0
Goodwill	467		$ 467
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	0	$ 1
Unearned Revenue, Additions	(9)
Unearned Revenue, Amortization Expense	2
Unearned Revenue, Unrealized Gain (Loss) on Investment	$ 9
Minimum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset	0.05%
Maximum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset	4.01%
Voba [Member]
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains	$ (40)		(22)
Dac [Member]
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains	(5)		$ 0
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	$ 2	$ 2

Intangible Assets - Estimated A

Intangible Assets - Estimated Amortization Expense for VOBA in Future Fiscal Periods (Detail)	Mar. 31, 2019USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2019	$ 48,000,000
2020	83,000,000
2021	89,000,000
2022	84,000,000
2023	75,000,000
Thereafter	$ 385,000,000

Debt - Narrative (Detail)

Debt - Narrative (Detail) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 541
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	$ 0	$ 0
Interest rate if revolver drawn	5.00%
Remaining borrowing capacity	$ 250
Predecessor
Debt Instrument [Line Items]
Long-term Debt		$ 541

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 541
Interest expense excluding amortization	8
Amortization of debt issuance costs	0
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	0		$ 0
Interest expense excluding amortization	0
Amortization of debt issuance costs	$ 0
Predecessor
Debt Instrument [Line Items]
Long-term Debt			$ 541
Interest expense excluding amortization		$ 5
Amortization of debt issuance costs		0
Predecessor | Revolving Credit Facility
Debt Instrument [Line Items]
Interest expense excluding amortization		1
Amortization of debt issuance costs		$ 0

Equity - Schedule of Dividends

Equity - Schedule of Dividends (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 14, 2015	Nov. 12, 2015	Mar. 31, 2019	Dec. 31, 2018	Nov. 30, 2015
Accelerated Share Repurchases [Line Items]
Common stock, shares outstanding (in shares)			211,660,974	211,660,974	221,661,000
Cash dividend per common share (in dollars per share)		$ 0.01
Total cash paid	$ 2

Equity - Schedule of Dividend_2

Equity - Schedule of Dividends Declared (Details) $ / shares in Units, shares in Thousands, shareholder in Thousands, $ in Thousands	Dec. 15, 2020	May 07, 2019$ / shares	Apr. 01, 2019USD ($)shares	Mar. 15, 2019shares	Apr. 01, 2018USD ($)shares	Mar. 15, 2018shareholder	Nov. 12, 2015$ / shares	Mar. 31, 2019USD ($)
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount								$ 150,000
Cash dividend per common share (in dollars per share) | $ / shares							$ 0.01
Preferred Stock | Series A Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Number of Shareholders				298		277
Preferred Stock | Series B Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Number of Shareholders				108		101
Subsequent Event [Member]
Class of Stock [Line Items]
Cash dividend per common share (in dollars per share) | $ / shares		$ 0.01
Stock Repurchase Program Expiration Date	Dec. 15, 2020
Subsequent Event [Member] | Preferred Stock | Series A Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Total cash paid			$ 0		$ 0
Total shares paid in kind (in thousands) | shares			6		5
Subsequent Event [Member] | Preferred Stock | Series B Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Total cash paid			$ 0		$ 0
Total shares paid in kind (in thousands) | shares			2		1

Stock Compensation - Narrative

Stock Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	Mar. 31, 2019	May 15, 2018	Mar. 31, 2019	Dec. 31, 2018	Aug. 08, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	5,588,000		5,588,000
2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)					15,006,000
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			1,699,000
Vested and exercisable at end of period (in shares)	485,000
Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date			$ 3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 76		$ 76
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	6 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	7 years
Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 6.82		$ 6.82	$ 0
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date			$ 1
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			147,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 6.82
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value			$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period			0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value			$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	147,000		147,000	0
Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 9.19		$ 9.19	$ 8.95
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date			$ 4
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			424,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 8.64
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			(59,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value			$ 10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period			(10,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value			$ 8.96
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	711,000		711,000	356,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities	$ 0		$ 0
Officer [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		1,699,000
Director [Member] | Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			147,000
Management [Member] | Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			424,000
FGL Holdings [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Price	$ 7.87		$ 7.87
Service Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		485,000
Service and Return on Equity Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		607,000
Service and Stock Price Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		607,000

Stock Compensation - Schedule o

Stock Compensation - Schedule of Stock Based Compensation Costs (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Related tax benefit	$ 0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1
Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1
Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	0
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1
FGL Incentive Plan [Member] | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1
FGL Incentive Plan [Member] | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	$ 0

Stock Compensation - Summary of

Stock Compensation - Summary of Unrecognized Stock Compensation Expense (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 22
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	3 years
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 19
FGL Incentive Plan [Member] | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 18
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	3 years
FGL Incentive Plan [Member] | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 1
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year
Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 3
Management Incentive Plan [Member] | Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 3
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	3 years

Stock Compensation - Summary _2

Stock Compensation - Summary of Stock Options Outstanding and Related Activity (Details) - $ / shares shares in Thousands	Mar. 31, 2019	Feb. 26, 2019	May 15, 2018	Mar. 31, 2019	Dec. 31, 2018
FGL Incentive Plan [Member]
Options (in shares):
Stock options outstanding at beginning of period (in shares)				13,007
Granted (in shares)				1,699
Exercised (in shares)				0
Forfeited or expired (in shares)				(1,869)
Stock options outstanding at end (in shares)	12,837			12,837
Vested and exercisable at end of period (in shares)	485
Vested or projected to vest (in shares)	12,837			12,837
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (USD per share)				$ 9.68
Granted (USD per share)				10
Exercised (USD per share)				0
Forfeited or expired (USD per share)				(10)
Stock options outstanding at end of period (USD per share)	$ 9.67			9.67
Vested and exercisable at end of period (USD per share)	10
Vested and projected to vest (in dollars per share)	$ 9.67			$ 9.67
Equity Option [Member] | Officer [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)			1,699
Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	147			147	0
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 6.82			$ 6.82	$ 0
Granted (in shares)				147
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value				$ 6.82
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value				$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period				0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value				$ 0
Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	711			711	356
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 9.19			$ 9.19	$ 8.95
Granted (in shares)				424
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value				$ 8.64
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				(59)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value				$ 10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period				(10)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value				$ 8.96
Service Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)			485
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 1.68
Service and Return on Equity Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)			607
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		1.74
Service and Stock Price Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)			607
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 1.26

Stock Compensation - Assumption

Stock Compensation - Assumptions Used in Determination of Grant Date Fair Values Using Black-Scholes Option Pricing Model (Details) - Equity Option [Member] - FGL Incentive Plan [Member]	Feb. 26, 2019$ / shares
Service Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.68
Risk-free interest rate	2.48%
Assumed dividend yield	0.00%
Expected option term	5 years 9 months
Volatility	26.00%
Service and Return on Equity Performance Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.74
Risk-free interest rate	2.50%
Assumed dividend yield	0.00%
Expected option term	6 years
Volatility	26.00%
Service and Stock Price Performance Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.26
Risk-free interest rate	2.54%
Assumed dividend yield	0.00%
share-based compensation arrangement by share-based payment award, fair value assumptions, contractual term	7 years
Volatility	26.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Early Exercise Multiple	2.8
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Cost of Equity	10.50%

Stock Compensation - Summary _3

Stock Compensation - Summary of Restricted Stock and Restricted Stock Units Outstanding and Related Activity (Details) - FGL Incentive Plan [Member] - Restricted shares shares in Thousands	3 Months Ended
	Mar. 31, 2019$ / sharesshares
Shares:
Restricted shares outstanding at beginning of period (in shares) | shares	0
Granted (in shares) | shares	147
Vested (in shares) | shares	0
Restricted shares outstanding at end of period (in shares) | shares	147
Weighted Average Grant Date Fair Value (in dollars per share):
Average grant date fair value outstanding at beginning of period (USD per share) | $ / shares	$ 0
Average grant date fair value, Granted (USD per share) | $ / shares	6.82
Average grant date fair value, Exercised (USD per share) | $ / shares	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares	0
Average grant date fair value, Forfeited or Expired (USD per share) | $ / shares	$ 0
Average grant date fair value outstanding at end of period (USD per share) | $ / shares	$ 6.82

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Tax Credit Carryforward [Line Items]
Effective tax rate	5.00%	38.00%
Valuation allowance	$ 33,000,000
Deferred Tax Assets, Gross	$ 316,000,000

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Investment Commitments (Details) - Commitment to Invest $ in Millions	Mar. 31, 2019USD ($)
Other Commitments [Line Items]
Unfunded investment commitment	$ 1,158
Other invested assets
Other Commitments [Line Items]
Unfunded investment commitment	1,093
Equity securities
Other Commitments [Line Items]
Unfunded investment commitment	21
Fixed maturity securities, available-for-sale
Other Commitments [Line Items]
Unfunded investment commitment	39
Other assets
Other Commitments [Line Items]
Unfunded investment commitment	$ 5

Commitments and Contingencies_2

Commitments and Contingencies - Narrative (Details)	Mar. 31, 2019USD ($)
Loss Contingencies [Line Items]
Accrued amount of guaranty fund assessments	$ 2
Estimated future premium tax deductions	$ 2

Reinsurance - Effect of Reinsur

Reinsurance - Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Benefits and Other Changes in Insurance Policy Reserves:
Net	$ 339
Traditional life insurance premiums
Premiums and other considerations:
Direct	57
Assumed	0
Ceded	(41)
Net	16
Benefits and Other Changes in Insurance Policy Reserves:
Direct	372
Assumed	20
Ceded	(53)
Net	$ 339
Predecessor
Benefits and Other Changes in Insurance Policy Reserves:
Net		$ (39)
Predecessor | Traditional life insurance premiums
Premiums and other considerations:
Direct		60
Assumed		0
Ceded		(42)
Net		18
Benefits and Other Changes in Insurance Policy Reserves:
Direct		41
Assumed		(21)
Ceded		(59)
Net		$ (39)

Reinsurance - Narrative (Detail

Reinsurance - Narrative (Details)	Dec. 28, 2018USD ($)	Mar. 31, 2019USD ($)	Sep. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Sep. 30, 2017USD ($)	Dec. 31, 2018USD ($)
Ceded Credit Risk [Line Items]
Reinsurance, Loss on Uncollectible Accounts in Period, Amount		$ 0	$ 0	$ 0	$ 0
Reinsurance Risk Charge Fee		0
Number of policies reinsured by foreign company not engaged in insurance				0
Funds withheld for reinsurance receivables, at fair value		837,000,000				$ 757,000,000
Funds Held under Reinsurance Agreements, Liability		653,000,000				$ 722,000,000
Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Ceded		0	$ 0	$ 0	$ 0
Reinsurance Retention Policy, Amount Retained	$ 758
Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsurance Retention Policy, Amount Retained	$ 4,000,000,000
FSRC [Member]
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value		286,000,000
Funds Held under Reinsurance Agreements, Liability		270,000,000
F&G Re [Member]
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value		551,000,000
Funds Held under Reinsurance Agreements, Liability		$ 527,000,000
2013 [Member] | Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Reinsured risk	40.00%
2001 Through 2012 [Member] | Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Reinsured risk	45.00%
2000 And Prior [Member] | Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Reinsured risk	63.00%
Minimum | Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsured risk	80.00%
Maximum | Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsured risk	90.00%

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - USD ($) shares in Thousands	Mar. 31, 2019	Dec. 31, 2018	Dec. 17, 2018	Mar. 31, 2019	Sep. 30, 2018	Mar. 31, 2018
Related Party Transaction [Line Items]
Related Party Transactions, Gain (Loss)				$ 0		$ 0
Management Fee Payable	$ 25,000,000	$ 20,000,000		25,000,000
Reimbursement Revenue				2,000,000
Related Party Transaction, Asset Carrying Value	1,549,000,000	1,461,000,000		1,549,000,000
Unrealized Loss on Foreign Currency Derivatives, before Tax	(4,000,000)	(2,000,000)
Subsidiary of Common Parent [Member]
Related Party Transaction [Line Items]
Benefits and other changes in policy reserves				0
Commitment to Invest
Related Party Transaction [Line Items]
Unfunded investment commitment	1,158,000,000			1,158,000,000
Commitment to Invest | Affiliated Entity
Related Party Transaction [Line Items]
Unfunded investment commitment	$ 971,000,000	$ 990,000,000		971,000,000
Preferred Stock | Affiliated Entity
Related Party Transaction [Line Items]
Total shares paid in kind (in thousands)					6
Residential Portfolio Segment [Member]
Related Party Transaction [Line Items]
Residential Mortgage Loans Purchased			$ 185,000,000	$ 12,000,000

Earnings Per Share - Summary of

Earnings Per Share - Summary of Basic and Diluted EPS (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2019	Sep. 30, 2018	Mar. 31, 2018	Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income (loss)	$ 171		$ 65
Less Preferred stock dividend	8		$ 7
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic	$ 163
Weighted-average common shares outstanding - basic (in shares)	219,645,679
Dilutive effect of unvested restricted stock and unvested performance restricted stock (in shares)	36,000
Weighted-average shares outstanding - diluted (in shares)	219,681,528
Net income (loss) per common share:
Basic (in USD per share)	$ 0.74
Diluted (in USD per share)	$ 0.74
Common Stock Warrants Outstanding	6,000,000	70,000,000
Preferred Stock, shares outstanding (in shares)	406,510		377,000	399,033
Preferred Stock
Net income (loss) per common share:
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	406,000
Stock Option Awards
Net income (loss) per common share:
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	1,737,000
Predecessor
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income (loss)			$ 65
Less Preferred stock dividend			7
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic			$ 58
Weighted-average common shares outstanding - basic (in shares)			214,370,000
Dilutive effect of unvested restricted stock and unvested performance restricted stock (in shares)			0
Weighted-average shares outstanding - diluted (in shares)			214,370,000
Net income (loss) per common share:
Basic (in USD per share)			$ 0.27
Diluted (in USD per share)			$ 0.27

Insurance Subsidiary Financia_2

Insurance Subsidiary Financial Information and Regulatory Matters - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	$ 100	$ 110
Non-permitted statutory accounting practices	(4)	(16)
Statutory capital and surplus	97	94
Increase (decrease) in statutory capital surplus	48	30
IOWA
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	$ 1	$ 0

Uncategorized Items - fgl-20190

Label	Element	Value
Treasury Stock [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	$ 0